| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2024 |
Ramos-Ruperto L, Arcos-Rueda MDM, de Miguel-Buckley R, Busca-Arenzana C, Mican R, Montejano R, Delgado-Hierro A, Montes ML, Valencia ME, Serrano L, Arribas JR, González J, Bernardino JI, Martín-Carbonero L. Sex differences in the effectiveness and tolerability of dolutegravir plus rilpivirine as a switch strategy in people living with HIV. Hiv Medicine. PMID 38379338 DOI: 10.1111/hiv.13617 |
0.01 |
|
| 2024 |
Montejano R, Arribas JR. COVID-19 Clinical Trials: Are Adaptive Methodologies the Solution? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 38366997 DOI: 10.1093/cid/ciae079 |
0.01 |
|
| 2023 |
Berenguer J, Calvo-Alcántara MJ, Alvaro-Meca A, Estévez JC, Basanta M, Ruiz S, Matáix ÁL, Bienzóbas C, Cosano L, Silva AP, Salas P, Gullón P, Franco M, Arribas JR, Molero JM, et al. Three Years of the Coronavirus Disease 2019 Pandemic in a European Region: A Population-Based Longitudinal Assessment in Madrid Between 2020 and 2022. Open Forum Infectious Diseases. 11: ofad635. PMID 38173846 DOI: 10.1093/ofid/ofad635 |
0.01 |
|
| 2023 |
Montejano R, Soler-Carracedo A, Borobia AM, Martin-Quiros A, Grandioso D, Cañada C, Roman A, Arribas JR. The Current Mismatch between COVID-19 Clinical Trial Design and The Evolving Profile of Hospitalized Patients: A Retrospective Cohort Analysis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 37882613 DOI: 10.1093/cid/ciad655 |
0.01 |
|
| 2023 |
Bernardino JI, Alejos B, Rodriguez-Centeno J, Esteban-Cantos A, Mora-Rojas B, Montejano R, De Miguel R, Montero-Alonso M, Ayerdi O, Hernández-Gutierrez C, Curran A, Arribas JR, Rodés B. Monocyte Activation and Ageing Biomarkers in the Development of Cardiovascular Ischaemic Events or Diabetes in People with HIV. Microorganisms. 11. PMID 37512990 DOI: 10.3390/microorganisms11071818 |
0.01 |
|
| 2023 |
Sax PE, Arribas JR, Orkin C, Lazzarin A, Pozniak A, DeJesus E, Maggiolo F, Stellbrink HJ, Yazdanpanah Y, Acosta R, Huang H, Hindman JT, Martin H, Baeten JM, Wohl D. Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials. Eclinicalmedicine. 59: 101991. PMID 37200995 DOI: 10.1016/j.eclinm.2023.101991 |
0.01 |
|
| 2023 |
Schoepf IC, Esteban-Cantos A, Thorball CW, Rodés B, Reiss P, Rodríguez-Centeno J, Riebensahm C, Braun DL, Marzolini C, Seneghini M, Bernasconi E, Cavassini M, Buvelot H, Thurnheer MC, Kouyos RD, ... ... Arribas JR, et al. Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years. The Lancet. Healthy Longevity. 4: e211-e218. PMID 37148893 DOI: 10.1016/S2666-7568(23)00037-5 |
0.01 |
|
| 2023 |
Corominas J, Garriga C, Prenafeta A, Moros A, Cañete M, Barreiro A, González-González L, Madrenas L, Güell I, Clotet B, Izquierdo-Useros N, Raïch-Regué D, Gallemí M, Blanco J, Pradenas E, ... ... Arribas JR, et al. Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial. The Lancet Regional Health. Europe. 28: 100613. PMID 37131861 DOI: 10.1016/j.lanepe.2023.100613 |
0.01 |
|
| 2023 |
López-Gálvez R, Rivera-Caravaca JM, Mandaglio-Collados D, Orenes-Piñero E, Lahoz Á, Hernández-Romero D, Martínez CM, Carpes M, Arribas JM, Cánovas S, Lip GYH, Marín F. Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 37: e22941. PMID 37115741 DOI: 10.1096/fj.202201965RR |
0.01 |
|
| 2023 |
Vásquez Manau J, Marcelo Calvo C, De Gea Grela A, Ramos Ruperto L, Serrano L, Busca Arenzana C, Micán R, de Miguel Buckley R, Montejano Sanchez R, Bernardino I, Valencia ME, Moreno V, Montes ML, Arribas JR, González J, et al. Epidemiological characteristic and prognosis changes in chronic hepatitis B in people living with HIV. Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.). PMID 37003903 DOI: 10.1016/j.eimce.2023.03.002 |
0.01 |
|
| 2023 |
De Miguel R, Rial-Crestelo D, Dominguez-Dominguez L, Montejano R, Esteban-Cantos A, Aranguren-Rivas P, Stella-Ascariz N, Bisbal O, Bermejo-Plaza L, Garcia-Alvarez M, Alejos B, Hernando A, Santacreu-Guerrero M, Cadiñanos J, Mayoral M, ... ... Arribas JR, et al. Corrigendum to "Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)". Ebiomedicine. 89: 104486. PMID 36806001 DOI: 10.1016/j.ebiom.2023.104486 |
0.01 |
|
| 2023 |
Gibas KM, Arribas JR, Cahn P, Daar ES, Taiwo BO. Need for clear inclusion criteria in reviews of antiretroviral treatments - Authors' reply. The Lancet. Hiv. PMID 36773626 DOI: 10.1016/S2352-3018(23)00006-1 |
0.01 |
|
| 2023 |
Calderón-Parra J, Guisado-Vasco P, Montejano-Sánchez R, Estrada V, Cuevas-Tascón G, Aguareles J, Arribas J, Erro-Iribarren M, Calvo-Salvador M, Fernández-Cruz A, Ramos-Martínez A, Muñez-Rubio E. Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort. Journal of Clinical Medicine. 12. PMID 36769511 DOI: 10.3390/jcm12030864 |
0.01 |
|
| 2023 |
Butta NV, Arias-Salgado EG, Manzano EM, Acuña P, Álvarez Román MT, Buño-Soto A, Ramos Ramos JC, Belda-Iniesta C, Frías J, Carcas AJ, Martínez de Soto L, de Miguel Buckley R, Lora D, García-Morales MT, Borobia AM, ... Arribas JR, et al. No changes in haemostasis after COVID-19-heterologous vaccination schedule: a sub analysis of the phase 2 CombiVacS study. Research and Practice in Thrombosis and Haemostasis. 100049. PMID 36685004 DOI: 10.1016/j.rpth.2023.100049 |
0.01 |
|
| 2023 |
Trøseid M, Arribas JR. Which trial do we need? Management of elderly, fragile, fully vaccinated patients hospitalized for SARS-CoV-2 infection. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. PMID 36641054 DOI: 10.1016/j.cmi.2023.01.006 |
0.01 |
|
| 2023 |
Esteban-Cantos A, Rodríguez-Centeno J, Silla JC, Barruz P, Sánchez-Cabo F, Saiz-Medrano G, Nevado J, Mena-Garay B, Jiménez-González M, de Miguel R, Bernardino JI, Montejano R, Cadiñanos J, Marcelo C, Gutiérrez-García L, ... ... Arribas JR, et al. Effect of HIV infection and antiretroviral therapy initiation on genome-wide DNA methylation patterns. Ebiomedicine. 88: 104434. PMID 36640455 DOI: 10.1016/j.ebiom.2022.104434 |
0.01 |
|
| 2023 |
Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, et al. Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial. Critical Care (London, England). 27: 9. PMID 36627655 DOI: 10.1186/s13054-022-04205-8 |
0.01 |
|
| 2023 |
de la Calle-Prieto F, Estébanez Muñoz M, Ramírez G, Díaz-Menéndez M, Velasco M, Azkune Galparsoro H, Salavert Lletí M, Mata Forte T, Blanco JL, Mora-Rillo M, Arsuaga M, de Miguel Buckley R, Arribas JR, Membrillo FJ. Treatment and prevention of monkeypox. Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.). PMID 36624034 DOI: 10.1016/j.eimce.2022.12.010 |
0.01 |
|
| 2022 |
De Miguel Buckley R, Rial-Crestelo D, Montejano R, Pinto A, Jimenez-Gonzalez M, Lagarde M, Esteban-Cantos A, Aranguren-Rivas P, Cadiñanos J, Bisbal O, Castro JM, Santacreu-Guerrero M, Bermejo-Plaza L, Moreno V, Hernando A, ... ... Arribas JR, et al. Long-term Evaluation of Residual Viremia in a Clinical Trial of Dolutegravir Plus Lamivudine as Maintenance Treatment for Participants With and Without Prior Lamivudine Resistance. Open Forum Infectious Diseases. 9: ofac610. PMID 36447613 DOI: 10.1093/ofid/ofac610 |
0.01 |
|
| 2022 |
Del Amo J, Polo R, Moreno S, Martínez E, Cabello A, Iribarren JA, Curran A, Macías J, Montero M, Dueñas C, Mariño AI, de la Cámara SP, Díaz A, Arribas JR, Jarrín I, et al. Tenofovir disoproxil fumarate/emtricitabine and severity of coronavirus disease 2019 in people with HIV infection. Aids (London, England). 36: 2171-2179. PMID 36382436 DOI: 10.1097/QAD.0000000000003372 |
0.01 |
|
| 2022 |
Gibas KM, Kelly SG, Arribas JR, Cahn P, Orkin C, Daar ES, Sax PE, Taiwo BO. Two-drug regimens for HIV treatment. The Lancet. Hiv. PMID 36309038 DOI: 10.1016/S2352-3018(22)00249-1 |
0.01 |
|
| 2022 |
Waters L, de Miguel-Buckley R, Poulin S, Arribas JR. Broadly Neutralizing Antibodies for HIV Treatment: Broad in Theory, Narrow in Reality. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 36303321 DOI: 10.1093/cid/ciac835 |
0.01 |
|
| 2022 |
de la Calle-Prieto F, Estébanez Muñoz M, Ramírez G, Díaz-Menéndez M, Velasco M, Azkune Galparsoro H, Salavert Lletí M, Mata Forte T, Blanco JL, Mora-Rillo M, Arsuaga M, de Miguel Buckley R, Arribas JR, Membrillo FJ. [Treatment and prevention of monkeypox]. Enfermedades Infecciosas Y Microbiologia Clinica. PMID 36249471 DOI: 10.1016/j.eimc.2022.08.001 |
0.01 |
|
| 2022 |
Polo R, García-Albéniz X, Terán C, Morales M, Rial-Crestelo D, Garcinuño MA, García Del Toro M, Hita C, Gómez-Sirvent JL, Buzón L, Díaz de Santiago A, Pérez Arellano JL, Sanz J, Bachiller P, Martínez Alfaro E, ... ... Arribas JR, et al. Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo controlled randomized trial in healthcare workers. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. PMID 35940567 DOI: 10.1016/j.cmi.2022.07.006 |
0.01 |
|
| 2022 |
Montejano R, de la Calle-Prieto F, Velasco M, Guijarro C, Queiruga-Parada J, Jiménez-González M, González-Ruano P, Martínez P, Goikoetxea AJ, Ibarrola M, Ciudad M, Gutiérrez Á, Torralba M, Díaz-Brasero A, Ryan P, ... ... Arribas JR, et al. Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe COVID-19: The PANCOVID Randomized Clinical Trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 35906838 DOI: 10.1093/cid/ciac628 |
0.01 |
|
| 2022 |
Grosso TM, Alcamí J, Arribas JR, Martín M, Sereti I, Tarr P, Cahn P, Clotet B, Sued O, Negredo E. HIV and aging, biological mechanisms, and therapies: What do we know? Aids Reviews. 25: 79-86. PMID 35901108 DOI: 10.24875/AIDSRev.21000085 |
0.01 |
|
| 2022 |
Micán R, Grela AG, Cadiñanos J, de Miguel R, Busca C, Bernardino JI, Valencia E, Montes ML, Montejano R, Moreno V, Valero IP, Serrano L, González-García J, Arribas JR, Martín-Carbonero L. Impact of Pre-Existing Nrti Resistance on the Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experience Patients: Real-World Data. Aids (London, England). PMID 35848506 DOI: 10.1097/QAD.0000000000003311 |
0.01 |
|
| 2022 |
Trøseid M, Hentzien M, Ader F, Cardoso SW, Arribas JR, Molina JM, Mueller N, Hites M, Bonnet F, Manuel O, Costagliola D, Grinsztejn B, Olsen IC, Yazdapanah Y, Calmy A. Immunocompromized patients have been neglected in Covid-19 trials: A call for action. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. PMID 35623577 DOI: 10.1016/j.cmi.2022.05.005 |
0.01 |
|
| 2022 |
Laufer G, Strauch JT, Terp KA, Salinas M, Arribas JM, Massetti M, Andreas M, Young CP. Real-world 6-month outcomes of minimally invasive aortic valve replacement with the EDWARDS INTUITY Elite valve system. Interactive Cardiovascular and Thoracic Surgery. PMID 35394527 DOI: 10.1093/icvts/ivac083 |
0.01 |
|
| 2022 |
Ryom L, De Miguel R, Cotter AG, Podlekareva D, Beguelin C, Waalewijn H, Arribas JR, Mallon PWG, Marzolini C, Kirk O, Bamford A, Rauch A, Molina JM, Kowalska JD, Guaraldi G, et al. Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021. Hiv Medicine. PMID 35338549 DOI: 10.1111/hiv.13268 |
0.01 |
|
| 2022 |
Montejano R, Marcelo C, Falces-Romero I, Del Valle LG, De Soto T, Garcia-Rodríguez J, Arribas JR. Efficacy of sotrovimab for persistent coronavirus disease-2019 in a severely immunocompromised person living with HIV. Aids (London, England). 36: 751-753. PMID 35323160 DOI: 10.1097/QAD.0000000000003179 |
0.01 |
|
| 2022 |
Martín-Carbonero L, de Miguel R, Serrano L, Bernardino JI, Valencia E, Busca C, Micán R, Montejano R, Moreno V, Pérez-Valero I, Arribas JR, González-García J, Montes M. Acute hepatitis B among HIV positive persons: A two-decade review of cases from a Spanish cohort. Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.). 40: 121-124. PMID 35249671 DOI: 10.1016/j.eimce.2020.09.008 |
0.01 |
|
| 2022 |
Rodés B, Cadiñanos J, Esteban-Cantos A, Rodríguez-Centeno J, Arribas JR. Ageing with HIV: Challenges and biomarkers. Ebiomedicine. 77: 103896. PMID 35228014 DOI: 10.1016/j.ebiom.2022.103896 |
0.01 |
|
| 2022 |
García-García I, Seco-Meseguer E, Ruiz-Seco P, Navarro-Jimenez G, Martínez-Porqueras R, Espinosa-Díaz M, Ortega-Albás JJ, Sagastagoitia I, García-Morales MT, Jiménez-González M, Martínez de Soto L, Bajo-Martínez AI, Del Palacio-Tamarit M, López-García R, Díaz-García L, ... ... Arribas JR, et al. Melatonin in the Prophylaxis of SARS-CoV-2 Infection in Healthcare Workers (MeCOVID): A Randomised Clinical Trial. Journal of Clinical Medicine. 11. PMID 35207411 DOI: 10.3390/jcm11041139 |
0.01 |
|
| 2022 |
Monserrat Villatoro J, Mejía-Abril G, Díaz García L, Zubiaur P, Jiménez González M, Fernandez Jimenez G, Cancio I, Arribas JR, Suarez Fernández C, Mingorance J, García Rodríguez J, Villagrasa Ferrer JR, Carcas AJ, Frías J, Abad-Santos F, et al. A Case-Control of Patients with COVID-19 to Explore the Association of Previous Hospitalisation Use of Medication on the Mortality of COVID-19 Disease: A Propensity Score Matching Analysis. Pharmaceuticals (Basel, Switzerland). 15. PMID 35056135 DOI: 10.3390/ph15010078 |
0.01 |
|
| 2022 |
Rodríguez-Centeno J, Esteban-Cantos A, Montejano R, Stella-Ascariz N, De Miguel R, Mena-Garay B, Saiz-Medrano G, Alejos B, Jiménez-González M, Bernardino JI, Cadiñanos J, Castro-Alvarez JM, Rodés B, Arribas JR. Effects of tenofovir on telomeres, telomerase and T cell maturational subset distribution in long-term aviraemic HIV-infected adults. The Journal of Antimicrobial Chemotherapy. PMID 35045162 DOI: 10.1093/jac/dkab492 |
0.01 |
|
| 2021 |
Arribas JR, Bhagani S, Lobo SM, Khaertynova I, Mateu L, Fishchuk R, Park WY, Hussein K, Kim SW, Ghosn J, Brown ML, Zhang Y, Gao W, Assaid C, Grobler JA, et al. Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with Covid-19. Nejm Evidence. 1: EVIDoa2100044. PMID 38319178 DOI: 10.1056/EVIDoa2100044 |
0.01 |
|
| 2021 |
Salto-Alejandre S, Palacios-Baena ZR, Arribas JR, Berenguer J, Carratalà J, Jarrín I, Ryan P, Miguel-Montero M, Rodríguez-Baño J, Pachón J. Impact of early interferon-β treatment on the prognosis of patients with COVID-19 in the first wave: A post hoc analysis from a multicenter cohort. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 146: 112572. PMID 34954640 DOI: 10.1016/j.biopha.2021.112572 |
0.01 |
|
| 2021 |
Schoepf IC, Thorball CW, Ledergerber B, Kootstra NA, Reiss P, Raffenberg M, Engel T, Braun DL, Hasse B, Thurnheer C, Marzolini C, Seneghini M, Bernasconi E, Cavassini M, Buvelot H, ... Arribas JR, et al. Telomere Length Declines In Persons Living With HIV Before Antiretroviral Therapy Start But Not After Viral Suppression: A Longitudinal Study Over >17 Years. The Journal of Infectious Diseases. PMID 34910812 DOI: 10.1093/infdis/jiab603 |
0.01 |
|
| 2021 |
de Santiago MS, Arribas JLG, Llamas YM, Becvarova I, Meyer H. Randomized, double-blind, placebo-controlled clinical trial measuring the effect of a dietetic food on dermatologic scoring and pruritus in dogs with atopic dermatitis. Bmc Veterinary Research. 17: 354. PMID 34798876 DOI: 10.1186/s12917-021-03063-w |
0.01 |
|
| 2021 |
Díaz NA, de Miguel R, Agüero F, Sued O, Arribas JR, Ambrosioni J. Prevention and Treatment of SARS-CoV2 Infection in People Living with HIV: The Need for Specific Data. Infectious Diseases and Therapy. 11: 1-13. PMID 34709579 DOI: 10.1007/s40121-021-00547-y |
0.01 |
|
| 2021 |
Cahn P, Madero JS, Arribas JR, Antinori A, Ortiz R, Clarke AE, Hung CC, Rockstroh JK, Girard PM, Sievers J, Man CY, Urbaityte R, Brandon DJ, Underwood M, Pappa KA, et al. Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy-naive adults with HIV-1 infection. Aids (London, England). PMID 34534138 DOI: 10.1097/QAD.0000000000003070 |
0.01 |
|
| 2021 |
Montejano R, Dominguez-Dominguez L, de Miguel R, Rial-Crestelo D, Esteban-Cantos A, Aranguren-Rivas P, García-Álvarez M, Alejos B, Bisbal O, Santacreu-Guerrero M, Hernando A, Bermejo-Plaza L, Cadiñanos J, Mayoral M, Castro JM, ... ... Arribas JR, et al. Detection of archived lamivudine-associated resistance mutations in virologically suppressed, lamivudine-experienced HIV-infected adults by different genotyping techniques (GEN-PRO study). The Journal of Antimicrobial Chemotherapy. PMID 34459889 DOI: 10.1093/jac/dkab323 |
0.01 |
|
| 2021 |
de Miguel Buckley R, Díaz-Menéndez M, García-Rodríguez J, Arribas JR. Seasonal coronavirus pneumonia after SARS-Cov-2 infection and vaccine: new frenemies? The Journal of Infectious Diseases. PMID 34414421 DOI: 10.1093/infdis/jiab421 |
0.01 |
|
| 2021 |
Díez C, Del Romero-Raposo J, Mican R, López JC, Blanco JR, Calzado S, Samperiz G, Portilla J, García-Fraile LJ, Gutiérrez F, Gómez-Sirvent JL, Suárez-García I, Amador C, Novella M, Arribas JR, et al. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study. Hiv Medicine. PMID 34324783 DOI: 10.1111/hiv.13145 |
0.01 |
|
| 2021 |
Berenguer J, Díez C, Martín-Vicente M, Mican R, Pérez-Elías MJ, García-Fraile LJ, Vidal F, Suárez-García I, Podzamczer D, Del Romero J, Pulido F, Iribarren JA, Gutiérrez F, Poveda E, Galera C, ... ... Arribas JR, et al. Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. PMID 34186209 DOI: 10.1016/j.cmi.2021.06.023 |
0.01 |
|
| 2021 |
Borobia AM, Carcas AJ, Pérez-Olmeda M, Castaño L, Bertran MJ, García-Pérez J, Campins M, Portolés A, González-Pérez M, García Morales MT, Arana-Arri E, Aldea M, Díez-Fuertes F, Fuentes I, Ascaso A, ... ... Arribas JR, et al. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial. Lancet (London, England). PMID 34181880 DOI: 10.1016/S0140-6736(21)01420-3 |
0.01 |
|
| 2021 |
Esteban-Cantos A, Montejano R, Rodríguez-Centeno J, Saiz-Medrano G, De Miguel R, Barruz P, Bernardino JI, Mena-Garay B, Cadiñanos J, Jiménez-González M, Nevado J, Valencia E, Mayoral-Muñoz M, Arribas JR, Rodés B. Longitudinal changes in epigenetic age acceleration in aviremic HIV-infected recipients of long-term antiretroviral treatment. The Journal of Infectious Diseases. PMID 34166509 DOI: 10.1093/infdis/jiab338 |
0.01 |
|
| 2021 |
Kayı İ, Madran B, Keske Ş, Karanfil Ö, Arribas JR, Psheniсhnaya N, Petrosillo N, Gönen M, Ergönül Ö. The seroprevalence of SARS-CoV-2 antibodies among health care workers before the Era of vaccination: A systematic review and meta-analysis. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. PMID 34116205 DOI: 10.1016/j.cmi.2021.05.036 |
0.01 |
|
| 2021 |
Condes E, Arribas JR. Impact of COVID-19 on Madrid hospital system. Enfermedades Infecciosas Y Microbiologia Clinica. 39: 256-257. PMID 34024971 DOI: 10.1016/j.eimc.2020.06.005 |
0.01 |
|
| 2021 |
Del Amo J, Polo R, Moreno S, Díaz A, Martínez E, Arribas JR, Jarrín I, Hernán MA. Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy. Annals of Internal Medicine. 174: 581-582. PMID 33872541 DOI: 10.7326/L20-1399 |
0.01 |
|
| 2021 |
Esteban-Cantos A, Rodríguez-Centeno J, Barruz P, Alejos B, Saiz-Medrano G, Nevado J, Martin A, Gayá F, De Miguel R, Bernardino JI, Montejano R, Mena-Garay B, Cadiñanos J, Florence E, Mulcahy F, ... ... Arribas JR, et al. Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial. The Lancet. Hiv. 8: e197-e205. PMID 33794182 DOI: 10.1016/S2352-3018(21)00006-0 |
0.01 |
|
| 2021 |
Díaz-Menéndez M, Trigo E, Borobia AM, Arsuaga M, de la Calle-Prieto F, de Miguel Buckley R, Lago M, Arribas JR. Presenting characteristics and outcomes of migrants in a cohort of hospitalized patients with COVID-19: Does the origin matter? Travel Medicine and Infectious Disease. 102027. PMID 33757850 DOI: 10.1016/j.tmaid.2021.102027 |
0.01 |
|
| 2021 |
Martínez-Alés G, Domingo-Relloso A, Arribas JR, Quintana-Díaz M, Hernán MA. Critical Care Requirements Under Uncontrolled Transmission of SARS-CoV-2. American Journal of Public Health. e1-e4. PMID 33734835 DOI: 10.2105/AJPH.2020.306151 |
0.01 |
|
| 2021 |
Gonzalez-Barbeito M, Arribas JM, Vazquez A, Carnero M, Sarralde JA, Cal-Purriños N, Cánovas SJ, Maroto L, Gutiérrez F, Hornero F, Bautista-Hernandez V. Risk Factors for Postoperative Pacemaker Implantation After Rapid Deployment Aortic Valve Replacement: Results from the RADAR Registry. Advances in Therapy. PMID 33665760 DOI: 10.1007/s12325-021-01622-z |
0.01 |
|
| 2021 |
Gutiérrez-Gutiérrez B, Del Toro MD, Borobia AM, Carcas A, Jarrín I, Yllescas M, Ryan P, Pachón J, Carratalà J, Berenguer J, Arribas JR, Rodríguez-Baño J. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study. The Lancet. Infectious Diseases. PMID 33636145 DOI: 10.1016/S1473-3099(21)00019-0 |
0.01 |
|
| 2021 |
Berenguer J, Borobia AM, Ryan P, Rodríguez-Baño J, Bellón JM, Jarrín I, Carratalà J, Pachón J, Carcas AJ, Yllescas M, Arribas JR. Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score. Thorax. PMID 33632764 DOI: 10.1136/thoraxjnl-2020-216001 |
0.01 |
|
| 2021 |
Martinón-Torres F, Halperin SA, Nolan T, Tapiéro B, Perrett KP, de la Cueva IS, García-Sicilia J, Stranak Z, Vanderkooi OG, Kosina P, Rumlarova S, Virta M, Arribas JMM, Miranda-Valdivieso M, Novas BA, et al. Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial. Vaccine. PMID 33612341 DOI: 10.1016/j.vaccine.2021.02.001 |
0.01 |
|
| 2021 |
Cadiñanos J, Montejano R, de Miguel Buckley R, Marcelo C, Arribas JR. Risks and benefits of reducing the number of drugs to treat HIV-1 infection. Expert Opinion On Drug Safety. PMID 33557651 DOI: 10.1080/14740338.2021.1887135 |
0.01 |
|
| 2021 |
Borobia A, García-García I, Díaz-García L, Rodríguez-Mariblanca A, Martínez de Soto L, Monserrat Villatoro J, Seco Meseguer E, González JJ, Frías Iniesta J, Ramírez García E, Arribas JR, Carcas-Sansuán AJ. Healthcare workers' reasons for choosing between two different COVID-19 prophylaxis trials in an acute pandemic context: Results from an online survey. Journal of Medical Internet Research. PMID 33556032 DOI: 10.2196/23441 |
0.01 |
|
| 2021 |
Perez-Martinez A, Ferreras C, Mora-Rillo M, Guerra P, Pascual-Miguel B, Mestre-Durán C, Borobia A, Carcas A, Quiroga J, García I, Sánchez-Zapardiel E, Gasior M, de Paz R, Marcos A, Vicario J, ... ... Arribas J, et al. A phase I/II dose-escalation single center study to evaluate the safety of infusion of memory t cells as adoptive therapy in coronavirus pneumonia and /or lymphopenia (release) Cytotherapy. 23: S29. DOI: 10.1016/s1465324921002905 |
0.01 |
|
| 2020 |
Martín-Carbonero L, de Miguel R, Serrano L, Bernardino JI, Valencia E, Busca C, Micán R, Montejano R, Moreno V, Pérez-Valero I, Arribas JR, González-García J, Montes M. Acute hepatitis B among HIV positive persons: A two-decade review of cases from a Spanish cohort. Enfermedades Infecciosas Y Microbiologia Clinica. PMID 33268188 DOI: 10.1016/j.eimc.2020.09.012 |
0.01 |
|
| 2020 |
Rial-Crestelo D, de Miguel R, Montejano R, Dominguez-Dominguez L, Aranguren-Rivas P, Esteban-Cantos A, Bisbal O, Santacreu-Guerrero M, Garcia-Alvarez M, Alejos B, Hernando A, Bermejo-Plaza L, Cadiñanos J, Mayoral M, Castro JM, ... ... Arribas JR, et al. Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study. The Journal of Antimicrobial Chemotherapy. PMID 33200210 DOI: 10.1093/jac/dkaa479 |
0.01 |
|
| 2020 |
Rodríguez-Baño J, Pachón J, Carratalà J, Ryan P, Jarrín I, Yllescas M, Arribas JR, Berenguer J. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19). Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. PMID 32860964 DOI: 10.1016/j.cmi.2020.08.010 |
0.01 |
|
| 2020 |
Latasa P, de Ory F, Arribas JR, Sánchez-Uriz MÁ, Sanchez-Arcilla I, Ordobás M, Negredo A, Trigo E, Delgado P, Marzola M, Lopaz MÁ, Sánchez-Seco MP, de la Calle-Prieto F, Ferrera P, Rodriguez E, et al. Absence of IgG antibodies among high-risk contacts of two confirmed cases of Crimean-Congo haemorrhagic fever in the autonomous region of Madrid (Spain). Journal of Infection and Public Health. PMID 32828715 DOI: 10.1016/j.jiph.2020.07.016 |
0.01 |
|
| 2020 |
Del Amo J, Polo R, Moreno S, Díaz A, Martínez E, Arribas JR, Jarrín I, Hernán MA. Antiretrovirals and risk of COVID-19 diagnosis and hospitalization in HIV-positive persons. Epidemiology (Cambridge, Mass.). PMID 32773469 DOI: 10.1097/EDE.0000000000001235 |
0.01 |
|
| 2020 |
Berenguer J, Ryan P, Rodríguez-Baño J, Jarrín I, Carratalà J, Pachón J, Yllescas M, Arribas JR. Characteristics and predictors of death among 4,035 consecutively hospitalized patients with COVID-19 in Spain. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. PMID 32758659 DOI: 10.1016/j.cmi.2020.07.024 |
0.01 |
|
| 2020 |
Refoyo E, Troya J, Trigo E, Guzmán-Martinez G, Valbuena-López S, Caro-Codón J, Rosillo S, Moreno-Yanguela M, Tamargo J, Arribas JR, Acquatella H, Lopez-Sendon J. Comparison of Noninvasive Cardiac Test Strategies for Newly Diagnosed Chagas Disease in a Non-Endemic Zone. The American Journal of Tropical Medicine and Hygiene. PMID 32700660 DOI: 10.4269/Ajtmh.20-0389 |
0.01 |
|
| 2020 |
Condes E, Arribas JR. Impact of COVID-19 on Madrid hospital system. Enfermedades Infecciosas Y Microbiologia Clinica. PMID 32680795 DOI: 10.1016/j.eimc.2020.06.005 |
0.01 |
|
| 2020 |
Del Amo J, Polo R, Moreno S, Díaz A, Martínez E, Arribas JR, Jarrín I, Hernán MA. Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy: A Cohort Study. Annals of Internal Medicine. PMID 32589451 DOI: 10.7326/M20-3689 |
0.01 |
|
| 2020 |
Borobia AM, Carcas AJ, Arnalich F, Álvarez-Sala R, Monserrat-Villatoro J, Quintana M, Figueira JC, Torres Santos-Olmo RM, García-Rodríguez J, Martín-Vega A, Buño A, Ramírez E, Martínez-Alés G, García-Arenzana N, Núñez MC, ... ... Arribas JR, et al. A Cohort of Patients with COVID-19 in a Major Teaching Hospital in Europe. Journal of Clinical Medicine. 9. PMID 32512688 DOI: 10.3390/jcm9061733 |
0.01 |
|
| 2020 |
Orkin C, DeJesus E, Sax PE, Arribas JR, Gupta SK, Martorell C, Stephens JL, Stellbrink HJ, Wohl D, Maggiolo F, Thompson MA, Podzamczer D, Hagins D, Flamm JA, Brinson C, et al. Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials. The Lancet. Hiv. 7: e389-e400. PMID 32504574 DOI: 10.1016/S2352-3018(20)30099-0 |
0.01 |
|
| 2020 |
García IG, Rodriguez-Rubio M, Mariblanca AR, de Soto LM, García LD, Villatoro JM, Parada JQ, Meseguer ES, Rosales MJ, González J, Arribas JR, Carcas AJ, de la Oliva P, Borobia AM. A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial. Trials. 21: 466. PMID 32493475 DOI: 10.1186/s13063-020-04436-6 |
0.01 |
|
| 2020 |
De Miguel R, Rial-Crestelo D, Dominguez-Dominguez L, Montejano R, Esteban-Cantos A, Aranguren-Rivas P, Stella-Ascariz N, Bisbal O, Bermejo-Plaza L, Garcia-Alvarez M, Alejos B, Hernando A, Santacreu-Guerrero M, Cadiñanos J, Mayoral M, ... ... Arribas JR, et al. Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO). Ebiomedicine. 55: 102779. PMID 32408111 DOI: 10.1016/j.ebiom.2020.102779 |
0.01 |
|
| 2020 |
Gaborit BJ, Bergmann JF, Mussini C, Arribas JR, Behrens G, Walmsley S, Pozniak A, Raffi F. Plea for multitargeted interventions for severe COVID-19. The Lancet. Infectious Diseases. PMID 32325035 DOI: 10.1016/S1473-3099(20)30312-1 |
0.01 |
|
| 2020 |
Ramos-Ramos JC, Lázaro-Perona F, Arribas JR, García-Rodríguez J, Mingorance J, Ruiz-Carrascoso G, Borobia AM, Paño-Pardo JR, Herruzo R, Arnalich F. Proof-of-concept trial of the combination of lactitol with and for the eradication of intestinal OXA-48-producing . Gut Pathogens. 12: 15. PMID 32280375 DOI: 10.1186/s13099-020-00354-9 |
0.01 |
|
| 2020 |
Chalouni M, Rodriguez-Centeno J, Samri A, Blanco J, Stella-Ascariz N, Wallet C, Knobel H, Zucman D, Alejos Ferreras B, Autran B, Thiebaut R, Raffi F, Arribas JR. Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1-positive individuals. Plos One. 15: e0230772. PMID 32267847 DOI: 10.1371/Journal.Pone.0230772 |
0.01 |
|
| 2020 |
Arribas JR, Arribas JR, Sanyal AJ, Soriano A, Chin BS, Chin BS, Kalimuddin S, Schreiber S, Elboudwarej E, Tian Y, Hyland RH, SenGupta D, Chokkalingam A, Osinusi A, Brainard DM, et al. 557. Impact of Concomitant Hydroxychloroquine Use on Safety and Efficacy of Remdesivir in Moderate COVID-19 Patients Open Forum Infectious Diseases. 7: S343-S344. DOI: 10.1093/ofid/ofaa439.751 |
0.01 |
|
| 2020 |
Diaz G, Arribas JR, Arribas JR, Robinson PA, Cattelan AM, Tashima KT, Tsang OT, Tsang OT, Chen Y, Chen Y, SenGupta D, Vendrame E, Blair C, Chokkalingam A, Osinusi A, et al. 73. Geographical Disparities in Clinical Outcomes of Severe COVID-19 Patients Treated with Remdesivir Open Forum Infectious Diseases. 7: S167-S167. DOI: 10.1093/ofid/ofaa439.383 |
0.01 |
|
| 2020 |
Bernardino J, Arribas J. Is Spain doing enough to reduce the cardiovascular risk of patients with human immunodeficiency virus infection? Revista ClíNica EspañOla (English Edition). 220: 182-183. DOI: 10.1016/j.rceng.2019.07.004 |
0.01 |
|
| 2019 |
Cahn P, Madero JS, Arribas JR, Antinori A, Ortiz R, Clarke AE, Hung CC, Rockstroh JK, Girard PM, Sievers J, Man CY, Urbaityte R, Brandon DJ, Underwood M, Tenorio AR, et al. Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 31834000 DOI: 10.1097/QAI.0000000000002275 |
0.01 |
|
| 2019 |
Arribas JM, Soriano L, Rivera-Caravaca JM, Lorenzo M, Muñoz C, Taboada R, Jiménez A, Martínez J, García-Puente J, Gutiérrez F, Manzano S, Cánovas S. Incidence and causes of pacemaker implantation during postoperative period of aortic valve replacement with rapid deployment prosthesis. Pacing and Clinical Electrophysiology : Pace. PMID 31677175 DOI: 10.1111/pace.13824 |
0.01 |
|
| 2019 |
Alejos B, Stella-Ascariz N, Montejano R, Rodriguez-Centeno J, Schwimmer C, Bernardino JI, Rodes B, Esser S, Goujard C, Sarmento-Castro R, De Miguel R, Esteban-Cantos A, Wallet C, Raffi F, Arribas JR, et al. Determinants of blood telomere length in antiretroviral treatment-naïve HIV-positive participants enrolled in the NEAT 001/ANRS 143 clinical trial. Hiv Medicine. PMID 31532902 DOI: 10.1111/hiv.12791 |
0.01 |
|
| 2019 |
Bernardino JI, Arribas JR. Is Spain doing enough to reduce the cardiovascular risk of patients with Human Immnodeficiency Virus infection? Revista Clinica Espanola. 220: 182-183. PMID 31405518 DOI: 10.1016/j.rce.2019.07.005 |
0.01 |
|
| 2019 |
Pozniak AL, Arribas JR. Dolutegravir-rilpivirine for virological suppression. The Lancet. Hiv. PMID 31307947 DOI: 10.1016/S2352-3018(19)30188-2 |
0.01 |
|
| 2019 |
Stellbrink HJ, Arribas JR, Stephens JL, Albrecht H, Sax PE, Maggiolo F, Creticos C, Martorell CT, Wei X, Acosta R, Collins SE, Brainard D, Martin H. Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial. The Lancet. Hiv. PMID 31068272 DOI: 10.1016/S2352-3018(19)30080-3 |
0.01 |
|
| 2019 |
Gupta SK, Post FA, Arribas JR, Jr JJE, Wohl DA, Clarke AE, Sax PE, Stellbrink HJ, Esser S, Pozniak AL, Podzamczer D, Waters L, Orkin C, Rockstroh JK, Mudrikova T, et al. Renal safety of tenofovir alafenamide vs tenofovir disoproxil fumarate: A pooled analysis of 26 clinical trials. Aids (London, England). PMID 30932951 DOI: 10.1097/QAD.0000000000002223 |
0.01 |
|
| 2019 |
Kuhn JH, Adachi T, Adhikari NKJ, Arribas JR, Bah IE, Bausch DG, Bhadelia N, Borchert M, Brantsæter AB, Brett-Major DM, Burgess TH, Chertow DS, Chute CG, Cieslak TJ, Colebunders R, et al. New filovirus disease classification and nomenclature. Nature Reviews. Microbiology. PMID 30926957 DOI: 10.1038/S41579-019-0187-4 |
0.01 |
|
| 2019 |
Bernardino JI, Mocroft A, Wallet C, de Wit S, Katlama C, Reiss P, Mallon PW, Richert L, Molina JM, Knobel H, Morlat P, Babiker A, Pozniac A, Raffi F, Arribas JR, et al. Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial. Plos One. 14: e0209911. PMID 30689664 DOI: 10.1371/Journal.Pone.0209911 |
0.01 |
|
| 2018 |
Tello-Montoliu A, Albaladejo P, Hernández-Romero D, Taboada R, Albacete CL, Arribas JM, Jara R, Veliz A, López-García C, Cánovas S, Valdés M, Rivera-Caravaca JM, Marín F. Bleeding Risk Prediction in Patients With Dual Antiplatelet Therapy Undergoing Coronary Artery Bypass Grafting Surgery Using a Rapid Point-of-Care Platelet Function Test. Circulation. Cardiovascular Interventions. 11: e007264. PMID 30525983 DOI: 10.1161/CIRCINTERVENTIONS.118.007264 |
0.01 |
|
| 2018 |
Cahn P, Madero JS, Arribas JR, Antinori A, Ortiz R, Clarke AE, Hung CC, Rockstroh JK, Girard PM, Sievers J, Man C, Currie A, Underwood M, Tenorio AR, Pappa K, et al. Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials. Lancet (London, England). PMID 30420123 DOI: 10.1016/S0140-6736(18)32462-0 |
0.01 |
|
| 2018 |
Thompson JA, Kityo C, Dunn D, Hoppe A, Ndashimye E, Hakim J, Kambugu A, van Oosterhout JJ, Arribas J, Mugyenyi P, Walker AS, Paton NI. Evolution of protease inhibitor resistance in HIV-1-infected patients failing protease inhibitor monotherapy as second-line therapy in low-income countries: an observational analysis within the EARNEST randomised trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30060027 DOI: 10.1093/cid/ciy589 |
0.01 |
|
| 2018 |
Lazaro-Perona F, Ramos JC, Sotillo A, Mingorance J, García-Rodriguez J, Ruiz-Carrascoso G, Paño-Pardo JR, Arribas JR, Herruzo R, Arnalich F. Intestinal persistence of a plasmid harboring the OXA-48 carbapenemase gene after hospital discharge. The Journal of Hospital Infection. PMID 30017896 DOI: 10.1016/j.jhin.2018.07.004 |
0.01 |
|
| 2018 |
Stella-Ascariz N, Montejano R, Rodriguez-Centeno J, Alejos B, Schwimmer C, Bernardino JI, Rodes B, Allavena C, Hoffmann C, Gisslén M, de Miguel R, Esteban-Cantos A, Wallet C, Raffi F, Arribas JR, et al. Blood Telomere Length Changes after Ritonavir-boosted Darunavir Combined with Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected with HIV-1. The Journal of Infectious Diseases. PMID 29982509 DOI: 10.1093/infdis/jiy399 |
0.01 |
|
| 2018 |
Luczkowiak J, Lasala F, Mora-Rillo M, Arribas JR, Delgado R. Broad Neutralizing Activity Against Ebolaviruses Lacking the Mucin-Like Domain in Convalescent Plasma Specimens From Patients With Ebola Virus Disease. The Journal of Infectious Diseases. PMID 29939289 DOI: 10.1093/infdis/jiy302 |
0.01 |
|
| 2018 |
Montejano R, Stella-Ascariz N, Monge S, Bernardino JI, Pérez-Valero I, Montes ML, Valencia E, Martín-Carbonero L, Moreno V, González-Garcia J, Rodriguez-Centeno J, Rodes B, Esteban Cantos A, Alejos B, de Miguel R, ... ... Arribas JR, et al. Impact of Nucleos(t)ide Reverse Transcriptase Inhibitors on Blood Telomere Length Changes in a Prospective Cohort of Aviremic HIV-1 infected Adults. The Journal of Infectious Diseases. PMID 29912427 DOI: 10.1093/infdis/jiy364 |
0.01 |
|
| 2018 |
Pérez-Molina JA, Martínez E, Blasco AJ, Arribas JR, Domingo P, Iribarren JA, Knobel H, Lázaro P, López-Aldeguer J, Lozano F, Mariño A, Miró JM, Moreno S, Negredo E, Pulido F, et al. Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults. Enfermedades Infecciosas Y Microbiologia Clinica. PMID 29884455 DOI: 10.1016/j.eimc.2018.04.010 |
0.01 |
|
| 2018 |
Young C, Laufer G, Kocher A, Solinas M, Alamanni F, Polvani G, Podesser BK, Aramendi JI, Arribas J, Bouchot O, Livi U, Massetti M, Terp K, Giot C, Glauber M. One-year outcomes after rapid-deployment aortic valve replacement. The Journal of Thoracic and Cardiovascular Surgery. 155: 575-585. PMID 29415382 DOI: 10.1016/j.jtcvs.2017.09.133 |
0.01 |
|
| 2018 |
Pericàs JM, Moreno A, Almela M, García-de-la-Mària C, Marco F, Muñoz P, Peña C, de Alarcón A, Río AD, Eworo A, Cruceta A, Paré JC, Mestres CA, Miró JM, ... ... Arribas JR, et al. Efficacy and Safety of Fosfomycin Plus Imipenem vs. Vancomycin for Complicated Bacteremia and Endocarditis Due to Methicillin-Resistant Staphylococcus aureus: A Randomized Clinical Trial. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. PMID 29408610 DOI: 10.1016/j.cmi.2018.01.010 |
0.01 |
|
| 2018 |
de Miguel Buckley R, Montejano R, Stella-Ascariz N, Arribas JR. New Strategies of ARV: the Road to Simplification. Current Hiv/Aids Reports. PMID 29353398 DOI: 10.1007/s11904-018-0371-6 |
0.01 |
|
| 2017 |
Stella-Ascariz N, Arribas JR, Paredes R, Li JZ. The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure. The Journal of Infectious Diseases. 216: S847-S850. PMID 29207001 DOI: 10.1093/infdis/jix430 |
0.01 |
|
| 2017 |
de Miguel R, Montejano R, Stella-Ascariz N, Arribas JR. A safety evaluation of raltegravir for the treatment of HIV. Expert Opinion On Drug Safety. 1-7. PMID 29199485 DOI: 10.1080/14740338.2018.1411903 |
0.01 |
|
| 2017 |
García-Bujalance S, Gutiérrez-Arroyo A, De la Calle F, Díaz-Menéndez M, Arribas JR, García-Rodríguez J, Arsuaga M. Persistence and infectivity of Zika virus in semen after returning from endemic areas: Report of 5 cases. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 96: 110-115. PMID 29053990 DOI: 10.1016/j.jcv.2017.10.006 |
0.01 |
|
| 2017 |
Pulido F, Ribera E, Lagarde M, Pérez-Valero I, Palacios R, Iribarren JA, Payeras A, Domingo P, Sanz J, Cervero M, Curran A, Rodríguez-Gómez FJ, Téllez MJ, Ryan P, Barrufet P, ... ... Arribas JR, et al. Dual therapy with darunavir and ritonavir plus lamivudine versus triple therapy with darunavir and ritonavir plus tenofovir disoproxil fumarate and emtricitabine or abacavir and lamivudine for maintenance of HIV-1 viral suppression: randomised, open label, non-inferiority DUAL-GESIDA 8014-RIS-EST45 trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29020293 DOI: 10.1093/cid/cix734 |
0.01 |
|
| 2017 |
Orkin C, Molina JM, Negredo E, Arribas JR, Gathe J, Eron JJ, Van Landuyt E, Lathouwers E, Hufkens V, Petrovic R, Vanveggel S, Opsomer M. Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial. The Lancet. Hiv. PMID 28993180 DOI: 10.1016/S2352-3018(17)30179-0 |
0.01 |
|
| 2017 |
Caniglia EC, Phillips A, Porter K, Sabin CA, Winston A, Logan R, Gill J, Vandenhende MA, Barger D, Lodi S, Moreno S, Arribas JR, Pacheco A, Cardoso SW, Chrysos G, et al. Commonly prescribed antiretroviral therapy regimens and incidence of AIDS-defining neurological conditions. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28991888 DOI: 10.1097/Qai.0000000000001562 |
0.01 |
|
| 2017 |
Negredo A, de la Calle-Prieto F, Palencia-Herrejón E, Mora-Rillo M, Astray-Mochales J, Sánchez-Seco MP, Bermejo Lopez E, Menárguez J, Fernández-Cruz A, Sánchez-Artola B, Keough-Delgado E, Ramírez de Arellano E, Lasala F, Milla J, Fraile JL, ... ... Arribas JR, et al. Autochthonous Crimean-Congo Hemorrhagic Fever in Spain. The New England Journal of Medicine. 377: 154-161. PMID 28700843 DOI: 10.1056/NEJMoa1615162 |
0.01 |
|
| 2017 |
de la Calle-Prieto F, Martín-Quirós A, Trigo E, Mora-Rillo M, Arsuaga M, Díaz-Menéndez M, Arribas JR. Therapeutic management of Crimean-Congo haemorrhagic fever. Enfermedades Infecciosas Y Microbiologia Clinica. PMID 28669587 DOI: 10.1016/j.eimc.2017.04.007 |
0.01 |
|
| 2017 |
Mora-Rillo M, Díaz-Menéndez M, Crespillo-Andujar C, Arribas JR. Autochthonous Crimean-Congo haemorrhagic fever in Spain: So much to learn. Enfermedades Infecciosas Y Microbiologia Clinica. PMID 28651786 DOI: 10.1016/j.eimc.2017.05.004 |
0.01 |
|
| 2017 |
Arribas JR, DeJesus E, van Lunzen J, Zurawski C, Doroana M, Towner W, Lazzarin A, Nelson M, McColl D, Andreatta K, Swamy R, Szwarcberg J, Nguyen T. Simplification to single-tablet regimen of elvitegravir, cobicistat, emtricitabine, tenofovir DF from multi-tablet ritonavir-boosted protease inhibitor plus coformulated emtricitabine and tenofovir DF regimens: week 96 results of STRATEGY-PI. Hiv Clinical Trials. 1-8. PMID 28555519 DOI: 10.1080/15284336.2017.1330440 |
0.01 |
|
| 2017 |
Halperin SA, Arribas JR, Rupp R, Andrews CP, Chu L, Das R, Simon JK, Onorato MT, Liu K, Martin J, Helmond FA. Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults. The Journal of Infectious Diseases. PMID 28549145 DOI: 10.1093/infdis/jix189 |
0.01 |
|
| 2017 |
Rivero A, Pérez-Molina JA, Blasco AJ, Arribas JR, Asensi V, Crespo M, Domingo P, Iribarren JA, Lázaro P, López-Aldeguer J, Lozano F, Martínez E, Moreno S, Palacios R, Pineda JA, et al. Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults. Enfermedades Infecciosas Y Microbiologia Clinica. PMID 28532596 DOI: 10.1016/j.eimc.2017.04.002 |
0.01 |
|
| 2017 |
Montejano R, Stella-Ascariz N, Monge S, Bernardino JI, Pérez-Valero I, Montes M, Valencia E, Martín-Carbonero L, Moreno V, González-García J, Arnalich F, Mingorance J, Berniches LP, Perona R, Arribas JR. Impact of antiretroviral treatment containing tenofovir difumarate on the telomere length of aviremic HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28418989 DOI: 10.1097/QAI.0000000000001391 |
0.01 |
|
| 2017 |
Arribas JR, Thompson M, Sax PE, Haas B, McDonald C, Wohl DA, DeJesus E, Clarke AE, Guo S, Wang H, Callebaut C, Plummer A, Cheng A, Das M, McCallister S. A Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil fumarate (TDF), Each Coformulated with Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: Week 144 Results. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28282300 DOI: 10.1097/QAI.0000000000001350 |
0.01 |
|
| 2016 |
González-Baeza A, Arribas JR, Pérez-Valero I, Monge S, Bayón C, Martín P, Rubio S, Carvajal F. Vocal emotion processing deficits in HIV-infected individuals. Journal of Neurovirology. PMID 27943048 DOI: 10.1007/s13365-016-0501-0 |
0.01 |
|
| 2016 |
Díaz-Menéndez M, de la Calle-Prieto F, Montero D, Antolín E, Vazquez A, Arsuaga M, Trigo E, García-Bujalance S, de la Calle M, Sánchez Seco P, de Ory F, Arribas JR. Initial experience with imported Zika virus infection in Spain. Enfermedades Infecciosas Y Microbiologia Clinica. PMID 27743683 DOI: 10.1016/j.eimc.2016.08.003 |
0.01 |
|
| 2016 |
Paño-Pardo JR, López Quintana B, Lázaro Perona F, Ruiz Carrascoso G, Romero-Gómez MP, Loeches Yagüe B, Díaz-Pollán B, Martínez-Virto A, Mingorance J, García Rodríguez J, Arribas JR, Gómez-Gil R. Community-Onset Bloodstream and Other Infections, Caused by Carbapenemase-Producing Enterobacteriaceae: Epidemiological, Microbiological, and Clinical Features. Open Forum Infectious Diseases. 3: ofw136. PMID 27703997 DOI: 10.1093/ofid/ofw136 |
0.01 |
|
| 2016 |
Arsuaga M, Bujalance SG, Díaz-Menéndez M, Vázquez A, Arribas JR. Probable sexual transmission of Zika virus from a vasectomised man. The Lancet. Infectious Diseases. 16: 1107. PMID 27676342 DOI: 10.1016/S1473-3099(16)30320-6 |
0.01 |
|
| 2016 |
Stella-Ascariz N, Montejano R, Pintado-Berninches L, Monge S, Bernardino JI, Pérez-Valero I, Montes ML, Mingorance J, Perona R, Arribas JR. Differential effects of Tenofovir, Abacavir, Emtricitabine and Darunavir on telomerase activity in vitro. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 27552152 DOI: 10.1097/QAI.0000000000001154 |
0.01 |
|
| 2016 |
Rivero A, Pérez-Molina JA, Blasco AJ, Arribas JR, Crespo M, Domingo P, Estrada V, Iribarren JA, Knobel H, Lázaro P, López-Aldeguer J, Lozano F, Moreno S, Palacios R, Pineda JA, et al. Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults. Enfermedades Infecciosas Y Microbiologia Clinica. PMID 27459919 DOI: 10.1016/j.eimc.2016.06.013 |
0.01 |
|
| 2016 |
Arribas JR, Luczkowiak J, Delgado R. Convalescent Plasma for Ebola Virus Disease. The New England Journal of Medicine. 374: 2498-500. PMID 27332914 DOI: 10.1056/NEJMc1602284#SA1 |
0.01 |
|
| 2016 |
Saumoy M, Llibre JM, Terrón A, Knobel H, Arribas J, Domingo P, Arroyo-Manzano D, Rivero A, Moreno S, Podzamczer D. MARAVIROC ONCE-DAILY: EXPERIENCE IN ROUTINE CLINICAL PRACTICE. Aids Research and Human Retroviruses. PMID 27250802 DOI: 10.1089/AID.2015.0386 |
0.01 |
|
| 2016 |
González-Baeza A, Carvajal F, Bayón C, Pérez-Valero I, Montes-Ramírez M, Arribas JR. Facial Emotion Processing in Aviremic HIV-infected Adults. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. PMID 27193364 DOI: 10.1093/arclin/acw023 |
0.01 |
|
| 2016 |
Iribarren JA, Rubio R, Aguirrebengoa K, Arribas JR, Baraia-Etxaburu J, Gutiérrez F, Lopez Bernaldo de Quirós JC, Losa JE, Miró JM, Moreno S, Pérez Molina J, Podzamczer D, Pulido F, Riera M, Rivero A, et al. Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015. Enfermedades Infecciosas Y Microbiologia Clinica. PMID 27056581 DOI: 10.1016/j.eimc.2016.02.025 |
0.01 |
|
| 2016 |
Stella-Ascariz N, Montejano R, Martin-Vicente M, Mingorance J, Pérez-Valero I, Bernardino JI, Arribas JR. Long-Term Control of Human Immunodeficiency Virus-1 Replication Despite Extensive Resistance to Current Antiretroviral Regimens: Clonal Analysis of Resistance Mutations in Proviral Deoxyribonucleic Acid. Open Forum Infectious Diseases. 3: ofw041. PMID 27006965 DOI: 10.1093/ofid/ofw041 |
0.01 |
|
| 2016 |
Iribarren JA, Rubio R, Aguirrebengoa K, Arribas JR, Baraia-Etxaburu J, Gutiérrez F, Lopez Bernaldo de Quirós JC, Losa JE, Miró JM, Moreno S, Pérez Molina J, Podzamczer D, Pulido F, Riera M, Rivero A, et al. Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015. Enfermedades Infecciosas Y Microbiologia Clinica. PMID 26976381 DOI: 10.1016/j.eimc.2016.02.004 |
0.01 |
|
| 2016 |
Uyeki TM, Mehta AK, Davey RT, Liddell AM, Wolf T, Vetter P, Schmiedel S, Grünewald T, Jacobs M, Arribas JR, Evans L, Hewlett AL, Brantsaeter AB, Ippolito G, Rapp C, et al. Clinical Management of Ebola Virus Disease in the United States and Europe. The New England Journal of Medicine. 374: 636-46. PMID 26886522 DOI: 10.1056/NEJMoa1504874 |
0.01 |
|
| 2016 |
Wohl D, Oka S, Clumeck N, Clarke A, Brinson C, Stephens J, Tashima K, Arribas JR, Rashbaum B, Cheret A, Brunetta J, Mussini C, Tebas P, Sax PE, Cheng A, et al. A Randomized, Double-Blind comparison of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil fumarate (TDF), each coformulated with Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for initial HIV-1 Treatment: Week 96 results. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 26829661 DOI: 10.1097/QAI.0000000000000940 |
0.01 |
|
| 2016 |
de la Calle-Prieto F, Arsuaga-Vicente M, Mora-Rillo M, Arnalich-Fernandez F, Arribas JR. [Ebola virus disease: Update]. Enfermedades Infecciosas Y Microbiologia Clinica. PMID 26774254 DOI: 10.1016/j.eimc.2015.11.013 |
0.01 |
|
| 2016 |
Sendagorta E, Bernardino JI, Álvarez-Gallego M, Feíto M, Feltes R, Beato MJ, Pérez-Molina JA, Yllescas M, Díaz-Almirón M, Arribas JR, González-García J, Herranz P. Topical cidofovir to treat high-grade anal intraepithelial neoplasia in HIV-infected patients: a pilot clinical trial. Aids (London, England). 30: 75-82. PMID 26731755 DOI: 10.1097/QAD.0000000000000886 |
0.01 |
|
| 2016 |
van Lunzen J, Antinori A, Cohen CJ, Arribas JR, Wohl DA, Rieger A, Rachlis A, Bloch M, Segal-Maurer S, Garner W, Porter D, Bosse M, Piontkowsky D, Chuck SK, De-Oertel S. Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study. Aids (London, England). 30: 251-9. PMID 26684822 DOI: 10.1097/QAD.0000000000000911 |
0.01 |
|
| 2016 |
Orkin C, Rjinders B, Stephan C, McKellar M, Kiertiburanakul S, Arribas J, Murphy D, Bloch M, Liu Y, Fordyce M, Yau S, McCallister S. P045 Switching from boosted atazanavir (ATV) plus FTC/TDF to a TAF-based single tablet regimen (STR): week 48 data in virologically suppressed adults Sexually Transmitted Infections. 92: A34.1-A34. DOI: 10.1136/sextrans-2016-052718.99 |
0.01 |
|
| 2015 |
Luczkowiak J, Arribas JR, Gómez S, VJiménez-Yuste V, de la Calle F, Viejo A, Delgado R. Specific neutralizing response in plasma from convalescent patients of Ebola Virus Disease against the West Africa Makona variant of Ebola virus. Virus Research. PMID 26739425 DOI: 10.1016/j.virusres.2015.12.019 |
0.01 |
|
| 2015 |
Pozniak A, Arribas JR, Gathe J, Gupta SK, Post FA, Bloch M, Avihingsanon A, Crofoot G, Benson P, Lichtenstein K, Ramgopal M, Chetchotisakd P, Custodio JM, Abram ME, Wei X, et al. Switching to tenofovir alafenamide, coformulated with elvitegravir, cobicistat, and emtricitabine, in HIV-infected patients with renal impairment: 48 week results from a single-arm, multi-center, open-label, Phase 3 study. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 26627107 DOI: 10.1097/Qai.0000000000000908 |
0.01 |
|
| 2015 |
Hernández-Romero D, Lahoz Á, Roldan V, Jover E, Romero-Aniorte AI, Martinez CM, Jara-Rubio R, Arribas JM, Garcia-Alberola A, Cánovas S, Valdés M, Marín F. Von Willebrand factor is associated with atrial fibrillation development in ischaemic patients after cardiac surgery. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. PMID 26566941 DOI: 10.1093/europace/euv354 |
0.01 |
|
| 2015 |
Mills A, Arribas JR, Andrade-Villanueva J, DiPerri G, Van Lunzen J, Koenig E, Elion R, Cavassini M, Madruga JV, Brunetta J, Shamblaw D, DeJesus E, Orkin C, Wohl DA, Brar I, et al. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study. The Lancet. Infectious Diseases. PMID 26538525 DOI: 10.1016/S1473-3099(15)00348-5 |
0.01 |
|
| 2015 |
Bernardino JI, Mocroft A, Mallon PW, Wallet C, Gerstoft J, Russell C, Reiss P, Katlama C, De Wit S, Richert L, Babiker A, Buño A, Castagna A, Girard PM, Chene G, ... ... Arribas JR, et al. Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial. The Lancet. Hiv. 2: e464-73. PMID 26520926 DOI: 10.1016/S2352-3018(15)00181-2 |
0.01 |
|
| 2015 |
Pérez-Valero I, Arribas JR. Second-line antiretroviral therapy and the human factor. The Lancet. Hiv. 2: e34-5. PMID 26424456 DOI: 10.1016/S2352-3018(15)00003-X |
0.01 |
|
| 2015 |
Antinori A, Clarke A, Svedhem-Johansson V, Arribas JR, Arenas-Pinto A, Fehr J, Gerstoft J, Horban A, Clotet B, Ripamonti D, Girard PM, Hill AM, Moecklinghoff C. Week 48 efficacy and central nervous system analysis of darunavir/ritonavir monotherapy versus darunavir/ritonavir with two nucleoside analogues. Aids (London, England). 29: 1811-20. PMID 26372387 DOI: 10.1097/QAD.0000000000000778 |
0.01 |
|
| 2015 |
Berenguer J, Rivero A, Blasco AJ, Arribas JR, Boix V, Clotet B, Domingo P, González-García J, Knobel H, Lázaro P, López JC, Llibre JM, Lozano F, Miró JM, Podzamczer D, et al. Costs and cost-effectiveness analysis of 2015 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults. Enfermedades Infecciosas Y Microbiologia Clinica. PMID 26321131 DOI: 10.1016/j.eimc.2015.07.012 |
0.01 |
|
| 2015 |
Gathe J, Arribas JR, Van Lunzen J, Garner W, Speck RM, Bender R, Shreay S, Nguyen T. Patient-Reported Symptoms over 48 Weeks in a Randomized, Open-Label, Phase 3b Non-inferiority Trial of Adults with HIV Switching to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir DF Versus Continuation of Ritonavir-Boosted Protease Inhibitor with Emtricitabine and Tenofovir DF. The Patient. 8: 445-54. PMID 26286337 DOI: 10.1007/s40271-015-0137-9 |
0.01 |
|
| 2015 |
Sepriano A, Roman-Blas JA, Little RD, Pimentel-Santos F, Arribas JM, Largo R, Branco JC, Herrero-Beaumont G. DXA in the assessment of subchondral bone mineral density in knee osteoarthritis--A semi-standardized protocol after systematic review. Seminars in Arthritis and Rheumatism. 45: 275-83. PMID 26188773 DOI: 10.1016/j.semarthrit.2015.06.012 |
0.01 |
|
| 2015 |
Pérez-Andreu J, Ray VG, Arribas JM, Sánchez SJ. Ellis-van Creveld syndrome in adulthood: extending the clinical spectrum. Singapore Medical Journal. 56: e110-1. PMID 26106249 DOI: 10.11622/smedj.2015097 |
0.01 |
|
| 2015 |
Arribas JR, Girard PM, Landman R, Pich J, Mallolas J, Martínez-Rebollar M, Zamora FX, Estrada V, Crespo M, Podzamczer D, Portilla J, Dronda F, Iribarren JA, Domingo P, Pulido F, et al. Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial. The Lancet. Infectious Diseases. 15: 785-92. PMID 26062880 DOI: 10.1016/S1473-3099(15)00096-1 |
0.01 |
|
| 2015 |
Mora-Rillo M, Arsuaga M, Ramírez-Olivencia G, de la Calle F, Borobia AM, Sánchez-Seco P, Lago M, Figueira JC, Fernández-Puntero B, Viejo A, Negredo A, Nuñez C, Flores E, Carcas AJ, Jiménez-Yuste V, ... ... Arribas JR, et al. Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain. The Lancet. Respiratory Medicine. PMID 26041403 DOI: 10.1016/S2213-2600(15)00180-0 |
0.01 |
|
| 2015 |
Berenguer J, Polo R, Aldeguer JL, Lozano F, Aguirrebengoa K, Arribas JR, Blanco JR, Boix V, Casado JL, Clotet B, Crespo M, Domingo P, Estrada V, García F, et al. Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015). Enfermedades Infecciosas Y Microbiología ClíNica. 33: 544-56. PMID 26021186 DOI: 10.1016/j.eimc.2015.03.017 |
0.01 |
|
| 2015 |
Estébanez M, Bernardino JI, Serrano L, Pérez-Valero I, Zamora FX, Montes-Ramírez ML, González-García JJ, Arribas JR. Switching from tenofovir containing regimens to boosted protease inhibitor monotherapy: Impact on renal function. Enfermedades Infecciosas Y Microbiologia Clinica. PMID 25735716 DOI: 10.1016/j.eimc.2015.01.013 |
0.01 |
|
| 2015 |
Yazdanpanah Y, Arribas JR, Malvy D. Treatment of Ebola virus disease. Intensive Care Medicine. 41: 115-7. PMID 25385474 DOI: 10.1007/s00134-014-3529-8 |
0.01 |
|
| 2015 |
Andrade-Villanueva J, Pozniak A, Arribas J, Gupta S, Post F, Avihingsanon A, Crofoot G, Lichtenstein K, Ramgopal M, Chetchotisakd P, Silva A, Fordyce M. P029: Safety of tenofovir alafenamide in renal impairment Journal of the International Aids Society. 18. DOI: 10.7448/IAS.18.3.20160 |
0.01 |
|
| 2015 |
Arribas JR, Girard PM, Landman R, Pich J, Mallolas J, Martínez-Rebollar M, Zamora FX, Estrada V, Crespo M, Podzamczer D, Portilla J, Dronda F, Iribarren JA, Domingo P, Pulido F, et al. Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A randomised, open-label, non-inferiority trial The Lancet Infectious Diseases. 15: 785-792. DOI: 10.1016/S1473-3099(15)00096-1 |
0.01 |
|
| 2015 |
Borobia A, Mora-Rillo M, Ramírez Olivencia G, Lago M, Arsuaga M, De la Calle F, Arnalich F, Arribas J, Carcas A. High dose favipiravir: first experience in a patient with Ebola Clinical Therapeutics. 37: e15-e16. DOI: 10.1016/J.CLINTHERA.2015.05.054 |
0.01 |
|
| 2015 |
Gathe J, Arribas JR, van Lunzen J, Garner W, Speck RM, Bender R, Shreay S, Nguyen T. Patient-Reported Symptoms over 48 Weeks in a Randomized, Open-Label, Phase 3b Non-inferiority Trial of Adults with HIV Switching to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir DF Versus Continuation of Ritonavir-Boosted Protease Inhibitor with Emtricitabine and Tenofovir DF Patient. DOI: 10.1007/s40271-015-0137-9 |
0.01 |
|
| 2014 |
Górriz JL, Gutiérrez F, Trullas JC, Arazo P, Arribas JR, Barril G, Cervero M, Cofan F, Domingo P, Estrada V, Fulladosa X, Galindo MJ, et al. Consensus document on the management of renal disease in HIV-infected patients. Nefrología : PublicacióN Oficial De La Sociedad EspañOla Nefrologia. 34: 1-81. PMID 25467377 DOI: 10.3265/Nefrologia.pre2014.Jul.12674 |
0.01 |
|
| 2014 |
Górriz JL, Gutiérrez F, Trullas JC, Arazo P, Arribas JR, Barril G, Cervero M, Cofan F, Domingo P, Estrada V, Fulladosa X, Galindo MJ, Gracia S, Iribarren JA, Knobel H, et al. Executive summary of the consensus document on the management of renal disease in HIV-infected patients. Nefrología : PublicacióN Oficial De La Sociedad EspañOla Nefrologia. 34: 768-88. PMID 25415577 DOI: 10.3265/Nefrologia.pre2014.Sep.12745 |
0.01 |
|
| 2014 |
Reeves I, Fisher M, Kegg S, Arribas J, Dau L, Garner W, Walker I, Nguyen T. Renal safety profile of STB in virologically suppressed subjects from two randomized phase 3b switch trials. Journal of the International Aids Society. 17: 19807. PMID 25397551 |
0.01 |
|
| 2014 |
Arribas J, Rizzardini G, Arasteh K, Zurawski C, Dietz C, Pontani D, Garner W, Nguyen T. Simplification to Stribild vs continuation of RTV-boosted DRV with FTC and TDF in virologically suppressed HIV adults: a STRATEGY-PI subgroup analysis. Journal of the International Aids Society. 17: 19805. PMID 25397549 |
0.01 |
|
| 2014 |
Arribas J, Girard PM, Paton N, Winston A, Marcelin AG, Elbirt D, Hill A, Hadacek MB. Efficacy of PI monotherapy versus triple therapy for 1964 patients in 10 randomised trials. Journal of the International Aids Society. 17: 19788. PMID 25397532 |
0.01 |
|
| 2014 |
Gonzalez-Baeza A, Perez-Valero I, Carvajal-Molina F, Bayon C, Montes-Ramirez M, Bernardino JI, Arribas JR. Facial emotional processing deficits in long-term HIV-suppressed patients. Journal of the International Aids Society. 17: 19664. PMID 25397414 |
0.01 |
|
| 2014 |
Gatell JM, Arribas JR, Lázaro P, Blasco A. Cost/efficacy analysis of preferred Spanish AIDS study group regimens and the dual therapy with LPV/r+3TC for initial ART in HIV infected adults. Journal of the International Aids Society. 17: 19603. PMID 25394107 |
0.01 |
|
| 2014 |
Valero IP, Baeza AG, Hernandez-Tamames JA, Monge S, Arnalich F, Arribas JR. Cerebral volumes, neuronal integrity and brain inflammation measured by MRI in patients receiving PI monotherapy or triple therapy. Journal of the International Aids Society. 17: 19578. PMID 25394085 |
0.01 |
|
| 2014 |
Cahn P, Villanueva JA, Arribas J, Gatell J, Lama J, Norton M, Patterson P, Madero JS, Sued O, Figueroa MI, Rolón MJ. Changes in lipid levels after 48 weeks of dual versus triple therapy observed in the GARDEL study. Journal of the International Aids Society. 17: 19554. PMID 25394061 |
0.01 |
|
| 2014 |
Antinori A, Arribas J, Fehr J, Girard PM, Horban A, Hill A, van Delft Y, Moecklinghoff C, Hill A. The PROTEA trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV-1 RNA below 50 copies/mL. Journal of the International Aids Society. 17: 19525. PMID 25394034 |
0.01 |
|
| 2014 |
Solomon A, Tennakoon S, Leeansyah E, Arribas J, Hill A, Van Delft Y, Moecklinghoff C, Lewin SR. No difference in the rate of change in telomere length or telomerase activity in HIV-infected patients after three years of darunavir/ritonavir with and without nucleoside analogues in the MONET trial. Plos One. 9: e109718. PMID 25368992 DOI: 10.1371/journal.pone.0109718 |
0.01 |
|
| 2014 |
Gorriz JL, Gutiérrez F, Trullàs JC, Arazo P, Arribas JR, Barril G, Cervero M, Cofán F, Domingo P, Estrada V, Fulladosa X, et al. [Executive summary of the recommendations on the evaluation and management of renal disease in human immunodeficiency virus-infected patients]. Enfermedades Infecciosas Y Microbiología ClíNica. 32: 583-97. PMID 25303781 DOI: 10.1016/j.eimc.2014.09.002 |
0.01 |
|
| 2014 |
Estébanez M, Stella-Ascariz N, Mingorance J, Pérez-Valero I, González-Baeza A, Bayón C, Lakatos B, Borobia A, Arnalich F, Arribas JR. A comparative study of neurocognitively impaired patients receiving protease inhibitor monotherapy or triple-drug antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes (1999). 67: 419-23. PMID 25197825 DOI: 10.1097/QAI.0000000000000337 |
0.01 |
|
| 2014 |
Pérez-Valero I, González-Baeza A, Estébanez M, Monge S, Montes-Ramírez ML, Bayón C, Pulido F, Bernardino JI, Zamora FX, González-García JJ, Lagarde M, Hernando A, Arnalich F, Arribas JR. A prospective cohort study of neurocognitive function in aviremic HIV-infected patients treated with 1 or 3 antiretrovirals. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: 1627-34. PMID 25114032 DOI: 10.1093/cid/ciu640 |
0.01 |
|
| 2014 |
Raffi F, Babiker AG, Richert L, Molina JM, George EC, Antinori A, Arribas JR, Grarup J, Hudson F, Schwimmer C, Saillard J, Wallet C, Jansson PO, Allavena C, Van Leeuwen R, et al. Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial. Lancet (London, England). 384: 1942-51. PMID 25103176 DOI: 10.1016/S0140-6736(14)61170-3 |
0.01 |
|
| 2014 |
Estébanez M, Stella-Ascariz N, Mingorance J, Pérez-Valero I, Bernardino JI, Zamora FX, Montes ML, González-GarcÃa JJ, Arribas JR. Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study. Bmc Infectious Diseases. 14: 379. PMID 25015544 DOI: 10.1186/1471-2334-14-379 |
0.01 |
|
| 2014 |
Paton NI, Kityo C, Hoppe A, Reid A, Kambugu A, Lugemwa A, van Oosterhout JJ, Kiconco M, Siika A, Mwebaze R, Abwola M, Abongomera G, Mweemba A, Alima H, Atwongyeire D, ... ... Arribas JR, et al. Assessment of second-line antiretroviral regimens for HIV therapy in Africa. The New England Journal of Medicine. 371: 234-47. PMID 25014688 DOI: 10.1056/NEJMoa1311274 |
0.01 |
|
| 2014 |
Berenguer J, Polo R, Lozano F, López Aldeguer J, Antela A, Arribas JR, Asensi V, Blanco JR, Clotet B, Domingo P, Galindo MJ, Gatell JM, González-García J, Iribarren JA, et al. Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014). Enfermedades Infecciosas Y Microbiología ClíNica. 32: 447-58. PMID 24986715 DOI: 10.1016/j.eimc.2014.02.018 |
0.01 |
|
| 2014 |
Arribas JR, Pialoux G, Gathe J, Di Perri G, Reynes J, Tebas P, Nguyen T, Ebrahimi R, White K, Piontkowsky D. Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week results of a randomised, open-label, phase 3b, non-inferiority trial. The Lancet. Infectious Diseases. 14: 581-9. PMID 24908551 DOI: 10.1016/S1473-3099(14)70782-0 |
0.01 |
|
| 2014 |
Caniglia EC, Cain LE, Justice A, Tate J, Logan R, Sabin C, Winston A, van Sighem A, Miro JM, Podzamczer D, Olson A, Arribas JR, Moreno S, Meyer L, del Romero J, et al. Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions. Neurology. 83: 134-41. PMID 24907236 DOI: 10.1212/Wnl.0000000000000564 |
0.01 |
|
| 2014 |
Cahn P, Andrade-Villanueva J, Arribas JR, Gatell JM, Lama JR, Norton M, Patterson P, Sierra Madero J, Sued O, Figueroa MI, Rolon MJ. Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial. The Lancet. Infectious Diseases. 14: 572-80. PMID 24783988 DOI: 10.1016/S1473-3099(14)70736-4 |
0.01 |
|
| 2014 |
González-Baeza A, Carvajal F, Bayón C, Pérez-Valero I, Estébanez M, Bernardino JI, Monge S, Lagarde M, Hernando A, Arnalich F, Arribas JR. Pattern of neurocognitive function in patients receiving boosted protease inhibitor monotherapy: a detailed neuropsychological study. Journal of Neurovirology. 20: 362-70. PMID 24760361 DOI: 10.1007/s13365-014-0251-9 |
0.01 |
|
| 2014 |
Tebas P, Sension M, Arribas J, Duiculescu D, Florence E, Hung CC, Wilkin T, Vanveggel S, Stevens M, Deckx H. Lipid levels and changes in body fat distribution in treatment-naive, HIV-1-Infected adults treated with rilpivirine or Efavirenz for 96 weeks in the ECHO and THRIVE trials. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: 425-34. PMID 24729492 DOI: 10.1093/cid/ciu234 |
0.01 |
|
| 2014 |
Pozniak AL, Arribas JR. FLAMINGO: how much rosier can antiretroviral therapy get? Lancet (London, England). 383: 2191-3. PMID 24698484 DOI: 10.1016/S0140-6736(14)60447-5 |
0.01 |
|
| 2014 |
Montes ML, Schapiro J, Pérez-Valero I, García-Bujalance S, Arribas JR. Long-term control of HIV replication with dolutegravir and pegylated interferon alpha-2a in an HIV-infected patient with sixtuple-class resistance. Aids (London, England). 28: 932-4. PMID 24614067 DOI: 10.1097/QAD.0000000000000173 |
0.01 |
|
| 2014 |
Cohen C, Wohl D, Arribas JR, Henry K, Van Lunzen J, Bloch M, Towner W, Wilkins E, Ebrahimi R, Porter D, White K, Walker I, Chuck S, De-Oertel S, Fralich T. Week 48 results from a randomized clinical trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults. Aids (London, England). 28: 989-97. PMID 24508782 DOI: 10.1097/QAD.0000000000000169 |
0.01 |
|
| 2014 |
Montes RamÃrez ML, Miró JM, Quereda C, Jou A, von Wichmann MÃ, Berenguer J, González-GarcÃa JJ, Hernando A, Ortega E, Sanz J, Arribas JR. Incidence of hepatocellular carcinoma in HIV-infected patients with cirrhosis: a prospective study. Journal of Acquired Immune Deficiency Syndromes (1999). 65: 82-6. PMID 24419065 DOI: 10.1097/QAI.0b013e3182a685dc |
0.01 |
|
| 2014 |
Hernández-Romero D, Vílchez JA, Lahoz Á, Romero-Aniorte AI, Orenes-Piñero E, Caballero L, Jara-Rubio R, Arribas JM, García-Alberola A, Valdés M, Lip GY, Marín F. High-sensitivity troponin T as a biomarker for the development of atrial fibrillation after cardiac surgery. European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association For Cardio-Thoracic Surgery. 45: 733-8. PMID 24163361 DOI: 10.1093/ejcts/ezt488 |
0.01 |
|
| 2013 |
Pérez J, Arribas JM, Cárdenas E, Gutiérrez F, Taboada R, Cassinello N. Radiotherapeutic management of the chyloperitoneum following abdominal aortic aneurysm repair. Journal of Vascular Surgery. Venous and Lymphatic Disorders. 1: 409-411. PMID 26992764 DOI: 10.1016/j.jvsv.2013.02.002 |
0.01 |
|
| 2013 |
Arribas J, Pulido F, Hill A, Delft Yv, Moecklinghoff C. Predictors of long-term HIV RNA suppression on darunavir/ritonavir monotherapy in the MONET trial. International Journal of Std & Aids. 24: 679-81. PMID 24014249 DOI: 10.1177/0956462413486461 |
0.01 |
|
| 2013 |
Blasco AJ, Llibre JM, Arribas JR, Boix V, Clotet B, Domingo P, González-GarcÃa J, Knobel H, López JC, Lozano F, Miró JM, Podzamczer D, SantamarÃa JM, Tuset M, Zamora L, et al. [Analysis of costs and cost-effectiveness of preferred GESIDA/National AIDS Plan regimens for initial antiretroviral therapy in human immunodeficiency virus infected adult patients in 2013]. Enfermedades Infecciosas Y Microbiologãa ClãNica. 31: 568-78. PMID 23969276 DOI: 10.1016/j.eimc.2013.06.002 |
0.01 |
|
| 2013 |
Pérez-Valero I, González-Baeza A, Estébanez M, Montes-Ramírez ML, Bayón C, Pulido F, Bernardino JI, Zamora FX, Monge S, Gaya F, Lagarde M, Rubio R, Hernando A, Arnalich F, Arribas JR. Neurocognitive impairment in patients treated with protease inhibitor monotherapy or triple drug antiretroviral therapy. Plos One. 8: e69493. PMID 23936029 DOI: 10.1371/journal.pone.0069493 |
0.01 |
|
| 2013 |
Moyle GJ, Stellbrink HJ, Compston J, Orkin C, Arribas JR, Domingo P, Granier C, Pearce H, Sedani S, Gartland M. 96-Week results of abacavir/lamivudine versus tenofovir/emtricitabine, plus efavirenz, in antiretroviral-naive, HIV-1-infected adults: ASSERT study. Antiviral Therapy. 18: 905-13. PMID 23899468 DOI: 10.3851/IMP2667 |
0.01 |
|
| 2013 |
Arribas JR, Eron J. Advances in antiretroviral therapy. Current Opinion in Hiv and Aids. 8: 341-9. PMID 23666392 DOI: 10.1097/COH.0b013e328361fabd |
0.01 |
|
| 2013 |
Pozniak AL, Arribas JR. A benchmark for management of drug resistant HIV. The Lancet. Infectious Diseases. 13: 561-2. PMID 23664332 DOI: 10.1016/S1473-3099(13)70113-0 |
0.01 |
|
| 2013 |
Rotger M, Glass TR, Junier T, Lundgren J, Neaton JD, Poloni ES, van 't Wout AB, Lubomirov R, Colombo S, Martinez R, Rauch A, Günthard HF, Neuhaus J, Wentworth D, van Manen D, ... ... Arribas JR, et al. Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 112-21. PMID 23532479 DOI: 10.1093/Cid/Cit196 |
0.01 |
|
| 2013 |
Geretti AM, Arribas JR, Lathouwers E, Foster GM, Yakoob R, Kinloch S, Hill A, van Delft Y, Moecklinghoff C. Dynamics of cellular HIV-1 DNA levels over 144 weeks of darunavir/ritonavir monotherapy versus triple therapy in the MONET trial. Hiv Clinical Trials. 14: 45-50. PMID 23372114 DOI: 10.1310/hct1401-45 |
0.01 |
|
| 2013 |
Arribas JR, Doroana M, Turner D, Vandekerckhove L, Streinu-Cercel A. Boosted protease inhibitor monotherapy in HIV-infected adults: outputs from a pan-European expert panel meeting. Aids Research and Therapy. 10: 3. PMID 23347595 DOI: 10.1186/1742-6405-10-3 |
0.01 |
|
| 2013 |
Arribas JR. Initial antiretroviral therapy: the dilemmas ahead. Enfermedades Infecciosas Y Microbiología ClíNica. 31: 68-70. PMID 22939567 DOI: 10.1016/j.eimc.2012.07.011 |
0.01 |
|
| 2013 |
Estebanez M, Stella-Ascariz N, Ruiz-Carrascoso G, Zamora FX, García-Bujalance S, Bernardino JI, Pérez-Valero I, Martin-Quirós A, Mingorance J, Arribas JR. Is etravirine and two nucleosides an option for HIV with an isolated K103N mutation? Aids (London, England). 27: 141-4. PMID 22914581 DOI: 10.1097/QAD.0b013e328358fcc2 |
0.01 |
|
| 2013 |
Cohen C, Wohl D, Arribas J, Henry K, Bloch M, Towner W, Ebrahimi R, Porter D, De-oertel S, Quercia R, Fralich T. STAR: Rilpivirine/Emtricitabine/TenofovirDF is non-inferior to Efavirenz/Emtricitabine/TenofovirDF in naive adult Latino, black & white subpopulations Journal of the International Aids Society. 16. DOI: 10.7448/IAS.16.2.18683 |
0.01 |
|
| 2012 |
Zúñiga RV, Arribas JL, Montes SP, Fernandez MN, Abad CG, Martin LG, González-Sagrado M. Application of Pediatric Appendicitis Score on the emergency department of a secondary level hospital. Pediatric Emergency Care. 28: 489-92. PMID 22653450 DOI: 10.1097/PEC.0b013e3182586d34 |
0.01 |
|
| 2012 |
García-Bujalance S, Francisco CN, Rubio JM, Arribas JR, Gutierrez A. Imported Plasmodium falciparum malaria in HIV-infected patients: a report of two cases. Malaria Journal. 11: 136. PMID 22540214 DOI: 10.1186/1475-2875-11-136 |
0.01 |
|
| 2012 |
Blasco AJ, Arribas JR, Boix V, Clotet B, Domingo P, González-GarcÃa J, Knobel H, López JC, Llibre JM, Lozano F, Miró JM, Podzamczer D, SantamarÃa JM, Tuset M, Zamora L, et al. [Costs and cost-efficacy analysis of the preferred treatments by GESIDA/National Plan for AIDS for the initial antiretroviral therapy in adult human immunodeficiency virus (HIV) infected patients in 2012]. Enfermedades Infecciosas Y Microbiologãa ClãNica. 30: 283-93. PMID 22525829 DOI: 10.1016/j.eimc.2012.02.016 |
0.01 |
|
| 2012 |
Arribas J, Hill A, Xi N, van Delft Y, Moecklinghoff C. Interleukin-6 and C-reactive protein levels after 3 years of treatment with darunavir/ritonavir monotherapy or darunavir/ritonavir + two nucleoside reverse transcriptase inhibitors in the MONET trial. The Journal of Antimicrobial Chemotherapy. 67: 1804-6. PMID 22454490 DOI: 10.1093/jac/dks102 |
0.01 |
|
| 2012 |
Pulido F, Arribas J, Hill A, Moecklinghoff C. No evidence for evolution of protease inhibitor resistance from standard genotyping, after three years of treatment with darunavir/ritonavir, with or without nucleoside analogues. Aids Research and Human Retroviruses. 28: 1167-9. PMID 22380531 DOI: 10.1089/AID.2011.0256 |
0.01 |
|
| 2012 |
Estébanez M, Arribas JR. Protease inhibitor monotherapy: what is its role? Current Hiv/Aids Reports. 9: 179-85. PMID 22362299 DOI: 10.1007/s11904-012-0112-1 |
0.01 |
|
| 2012 |
Estébanez-Muñoz M, Soto-Abánades CI, Ríos-Blanco JJ, Arribas JR. Updating our understanding of pulmonary disease associated with HIV infection. Archivos De BronconeumologíA. 48: 126-32. PMID 22257776 DOI: 10.1016/j.arbres.2011.12.001 |
0.01 |
|
| 2012 |
García-González C, García-Bujalance S, Ruiz-Carrascoso G, Arribas JR, González-García J, Bernardino JI, Pascual-Pareja JF, Martínez-Prats L, Delgado R, Mingorance J. Detection and quantification of the K103N mutation in HIV reverse transcriptase by pyrosequencing. Diagnostic Microbiology and Infectious Disease. 72: 90-6. PMID 22078905 DOI: 10.1016/j.diagmicrobio.2011.09.020 |
0.01 |
|
| 2012 |
van Lunzen J, Maggiolo F, Arribas JR, Rakhmanova A, Yeni P, Young B, Rockstroh JK, Almond S, Song I, Brothers C, Min S. Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial. The Lancet. Infectious Diseases. 12: 111-8. PMID 22018760 DOI: 10.1016/S1473-3099(11)70290-0 |
0.01 |
|
| 2012 |
Cohen C, Wohl D, Arribas J, Henry K, Lunzen JV, Bloch M, Towner W, Wilkins E, Wang H, White K, Poulin Porter D, Guyer B, Fralich T. STAR Study: single tablet regimen emtricitabine/rilpivirine/tenofovir DF is non-inferior to efavirenz/emtricitabine/tenofovir DF in ART-naïve adults Journal of the International Aids Society. 15. DOI: 10.7448/ias.15.6.18221 |
0.01 |
|
| 2012 |
Martinez E, González-Cordón A, Podzamczer D, Domingo P, Negredo E, Gutiérrez F, Portilla J, Ribera E, Murillas J, Arribas J, Santos I, Carton J, Peraire J, Pich J, Pérez I, et al. Metabolic effects of atazanavir/ritonavir vs darunavir/ritonavir in combination with tenofovir/emtricitabine in antiretroviral-naïve patients (ATADAR Study) Journal of the International Aids Society. 15. DOI: 10.7448/IAS.15.6.18202 |
0.01 |
|
| 2012 |
Pérez-Valero I, González-Baeza A, Estébanez M, Montes M, Bayon C, Pulido F, Cambrón I, Bernardino J, Zamora F, Monge S, Gaya F, Lagarde M, Rubio R, Hernando A, González-García J, ... ... Arribas J, et al. Prolonged treatment with boosted protease inhibitor monotherapy is not associated with a higher rate of neurocognitive impairment than triple drug ART Journal of the International Aids Society. 15. DOI: 10.7448/IAS.15.6.18179 |
0.01 |
|
| 2011 |
Blasco AJ, Arribas JR, Clotet B, Domingo P, González-GarcÃa J, López-Bernaldo JC, Llibre JM, Lozano F, Podzamczer D, SantamarÃa JM, Tuset M, Zamora L, Lázaro P, Gatell JM. [Costs and cost effectiveness analysis of preferred GESIDA regimens for initial antiretroviral therapy]. Enfermedades Infecciosas Y Microbiologãa ClãNica. 29: 721-30. PMID 22014894 DOI: 10.1016/j.eimc.2011.08.003 |
0.01 |
|
| 2011 |
Eron JJ, Rockstroh JK, Reynes J, Andrade-Villanueva J, Ramalho-Madruga JV, Bekker LG, Young B, Katlama C, Gatell-Artigas JM, Arribas JR, Nelson M, Campbell H, Zhao J, Rodgers AJ, Rizk ML, et al. Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial. The Lancet. Infectious Diseases. 11: 907-15. PMID 21933752 DOI: 10.1016/S1473-3099(11)70196-7 |
0.01 |
|
| 2011 |
McKinnon JE, Delgado R, Pulido F, Shao W, Arribas JR, Mellors JW. Single genome sequencing of HIV-1 gag and protease resistance mutations at virologic failure during the OK04 trial of simplified versus standard maintenance therapy. Antiviral Therapy. 16: 725-32. PMID 21817194 DOI: 10.3851/Imp1812 |
0.01 |
|
| 2011 |
Mathis S, Khanlari B, Pulido F, Schechter M, Negredo E, Nelson M, Vernazza P, Cahn P, Meynard JL, Arribas J, Bucher HC. Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis. Plos One. 6: e22003. PMID 21811554 DOI: 10.1371/journal.pone.0022003 |
0.01 |
|
| 2011 |
Llibre JM, Arribas JR, Domingo P, Gatell JM, Lozano F, Santos JR, Rivero A, Moreno S, Clotet B. Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy. Aids (London, England). 25: 1683-90. PMID 21673556 DOI: 10.1097/QAD.0b013e3283499cd9 |
0.01 |
|
| 2011 |
Perez-Valero I, Bayon C, Cambron I, Gonzalez A, Arribas JR. Protease inhibitor monotherapy and the CNS: peace of mind? The Journal of Antimicrobial Chemotherapy. 66: 1954-62. PMID 21672918 DOI: 10.1093/jac/dkr229 |
0.01 |
|
| 2011 |
Bernardino JI, Mora M, Zamora FX, Arribas B, Montes ML, Pascual-Pareja F, Jose BS, Peña JM, Arribas JR. Hypertension and isolated office hypertension in HIV-infected patients determined by ambulatory blood pressure monitoring: prevalence and risk factors. Journal of Acquired Immune Deficiency Syndromes (1999). 58: 54-9. PMID 21654497 DOI: 10.1097/QAI.0b013e3182267406 |
0.01 |
|
| 2011 |
Clumeck N, Rieger A, Banhegyi D, Schmidt W, Hill A, Van Delft Y, Moecklinghoff C, Arribas J. 96 week results from the MONET trial: a randomized comparison of darunavir/ritonavir with versus without nucleoside analogues, for patients with HIV RNA <50 copies/mL at baseline. The Journal of Antimicrobial Chemotherapy. 66: 1878-85. PMID 21652619 DOI: 10.1093/jac/dkr199 |
0.01 |
|
| 2011 |
Paño-Pardo JR, MartÃnez-Sánchez N, MartÃn-Quirós A, Romero-Gómez MP, Muñoz-Muñiz M, Sánchez-Pastor M, Ruiz G, San-José B, Prados MC, Mora-Rillo M, Rico-Nieto A, Arribas JR. Influenza-like illness in pregnant women during summertime: clinical, epidemiological and microbiological features. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 30: 1497-502. PMID 21556677 DOI: 10.1007/s10096-011-1248-4 |
0.01 |
|
| 2011 |
López-Diéguez M, Montes ML, Pascual-Pareja JF, Quereda C, Von Wichmann MA, Berenguer J, Tural C, Hernando A, González-GarcÃa J, Serrano L, Arribas JR. The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patients. Aids (London, England). 25: 899-904. PMID 21330908 DOI: 10.1097/QAD.0b013e3283454174 |
0.01 |
|
| 2011 |
Pulido F, Arribas JR, Hill A, Van Delft Y, Moecklinghoff C. Analysis of drug resistance during HIV RNA viraemia in the MONET trial of darunavir/ritonavir monotherapy. Antiviral Therapy. 16: 59-65. PMID 21311109 DOI: 10.3851/IMP1710 |
0.01 |
|
| 2011 |
Lejeune M, Miró JM, De Lazzari E, García F, Claramonte X, Martínez E, Ribera E, Arrizabalaga J, Arribas JR, Domingo P, Ferrer E, Plana M, Valls ME, Podzamczer D, Pumarola T, et al. Restoration of T cell responses to toxoplasma gondii after successful combined antiretroviral therapy in patients with AIDS with previous toxoplasmic encephalitis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 52: 662-70. PMID 21292671 DOI: 10.1093/cid/ciq197 |
0.01 |
|
| 2011 |
Paton NI, Meynard JL, Pulido F, Arenas-Pinto A, Girard PM, Arribas J. Inappropriate claim of 'failure of ritonavir-boosted lopinavir monotherapy in HIV' in the Monotherapy Switzerland/Thailand (MOST) trial. Aids (London, England). 25: 393-4. PMID 21239897 DOI: 10.1097/QAD.0b013e328342fb7b |
0.01 |
|
| 2011 |
Pérez-Valero I, Arribas JR. Protease inhibitor monotherapy. Current Opinion in Infectious Diseases. 24: 7-11. PMID 21150592 DOI: 10.1097/QCO.0b013e3283422cdf |
0.01 |
|
| 2011 |
Fox J, Peters B, Prakash M, Arribas J, Hill A, Moecklinghoff C. Improvement in vitamin D deficiency following antiretroviral regime change: Results from the MONET trial. Aids Research and Human Retroviruses. 27: 29-34. PMID 20854196 DOI: 10.1089/aid.2010.0081 |
0.01 |
|
| 2011 |
Paño-Pardo JR, MartÃn-Quirós A, Romero-Gómez M, Maldonado J, MartÃn-Vega A, Rico-Nieto A, Mora-Rillo M, Grill F, GarcÃa-RodrÃguez J, Arribas JR, Carratalá J, RodrÃguez-Baño J. Perspectives from Spanish infectious diseases professionals on 2009 A (H1N1) influenza: the third half. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 17: 845-50. PMID 20673267 DOI: 10.1111/j.1469-0691.2010.03322.x |
0.01 |
|
| 2010 |
Llibre JM, Antela A, Arribas JR, Domingo P, Gatell JM, López-Aldeguer J, Lozano F, Miralles C, Moltó J, Moreno S, Ortega E, Riera M, Rivero A, Villalonga C, Clotet B. [Role of fixed-dose combinations of antiretrovirals in HIV-1 therapy]. Enfermedades Infecciosas Y Microbiología ClíNica. 28: 615-20. PMID 20888082 DOI: 10.1016/j.eimc.2010.08.004 |
0.01 |
|
| 2010 |
Stellbrink HJ, Orkin C, Arribas JR, Compston J, Gerstoft J, Van Wijngaerden E, Lazzarin A, Rizzardini G, Sprenger HG, Lambert J, Sture G, Leather D, Hughes S, Zucchi P, Pearce H, et al. Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 51: 963-72. PMID 20828304 DOI: 10.1086/656417 |
0.01 |
|
| 2010 |
Perez-Valero I, Zamora FX, Pulido F, Arribas JR. Incorrect attribution of cerebrospinal fluid HIV-1 virological escape and lymphocytic meningitis to lopinavir/ritonavir monotherapy. Aids (London, England). 24: 2415-6. PMID 20827057 DOI: 10.1097/QAD.0b013e32833d56a5 |
0.01 |
|
| 2010 |
Winston A, Fätkenheuer G, Arribas J, Hill A, van Delft Y, Moecklinghoff C. Neuropsychiatric adverse events with ritonavir-boosted darunavir monotherapy in HIV-infected individuals: a randomised prospective study. Hiv Clinical Trials. 11: 163-9. PMID 20736152 DOI: 10.1310/hct1103-163 |
0.01 |
|
| 2010 |
Lifson AR, Neuhaus J, Arribas JR, van den Berg-Wolf M, Labriola AM, Read TR. Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial. American Journal of Public Health. 100: 1896-903. PMID 20724677 DOI: 10.2105/Ajph.2009.188664 |
0.01 |
|
| 2010 |
Miró JM, Manzardo C, Pich J, Domingo P, Ferrer E, Arribas JR, Ribera E, Arrizabalaga J, Loncá M, Cruceta A, de Lazzari E, Fuster M, Podzamczer D, Plana M, Gatell JM, et al. Immune reconstitution in severely immunosuppressed antiretroviral-naive HIV type 1-infected patients using a nonnucleoside reverse transcriptase inhibitor-based or a boosted protease inhibitor-based antiretroviral regimen: three-year results (The Advanz Trial): a randomized, controlled trial. Aids Research and Human Retroviruses. 26: 747-57. PMID 20624069 DOI: 10.1089/aid.2009.0105 |
0.01 |
|
| 2010 |
Mora M, Rodriguez-Castellano E, Pano-Pardo JR, González-GarcÃa J, Navarro C, Figueira JC, Arribas JR. Influenza A pandemic (H1N1) 2009 virus and HIV. Emerging Infectious Diseases. 16: 1175-6. PMID 20587202 DOI: 10.3201/eid1607.091339 |
0.01 |
|
| 2010 |
Arribas JR, Rivero A, Leal M, Sánchez-de la Rosa R. [Human immunodeficiency virus (HIV) type 1 with R5 tropism among HIV-1 antiretroviral-experienced patients in Spain]. Enfermedades Infecciosas Y Microbiología ClíNica. 28: 559-60. PMID 20400209 DOI: 10.1016/j.eimc.2009.10.005 |
0.01 |
|
| 2010 |
Estébanez-Muñoz M, Montes ML, Ruiz-Seco P, Royo-Orejas A, González-GarcÃa J, Arribas JR. [Demyelinating disease in human immunodeficiency virus-infected patients without severe immunodepression]. Enfermedades Infecciosas Y Microbiologãa ClãNica. 28: 608-11. PMID 20381930 DOI: 10.1016/j.eimc.2009.12.007 |
0.01 |
|
| 2010 |
Moreno S, López Aldeguer J, Arribas JR, Domingo P, Iribarren JA, Ribera E, Rivero A, Pulido F. The future of antiretroviral therapy: challenges and needs. The Journal of Antimicrobial Chemotherapy. 65: 827-35. PMID 20228080 DOI: 10.1093/jac/dkq061 |
0.01 |
|
| 2010 |
Arribas JR, Horban A, Gerstoft J, Fätkenheuer G, Nelson M, Clumeck N, Pulido F, Hill A, van Delft Y, Stark T, Moecklinghoff C. The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml. Aids (London, England). 24: 223-30. PMID 20010070 DOI: 10.1097/Qad.0B013E3283348944 |
0.01 |
|
| 2010 |
Rybniker J, Goede V, Mertens J, Ortmann M, Kulas W, Kochanek M, Benzing T, Arribas JR, Fätkenheuer G. Treatment of visceral leishmaniasis with intravenous pentamidine and oral fluconazole in an HIV-positive patient with chronic renal failure--a case report and brief review of the literature. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. 14: e522-5. PMID 19726213 DOI: 10.1016/j.ijid.2009.06.010 |
0.01 |
|
| 2010 |
Bernardino de la Serna JI, Zamora FX, Montes ML, García-Puig J, Arribas JR. [Hypertension, HIV infection, and highly active antiretroviral therapy]. Enfermedades Infecciosas Y Microbiología ClíNica. 28: 32-7. PMID 19409669 DOI: 10.1016/j.eimc.2008.07.005 |
0.01 |
|
| 2010 |
López-Aldeguer J, Aguirrebengoa K, Arribas JR, Esté JA, Kindelán JM. New targets and new drugs in the treatment of HIV. Enfermedades Infecciosas Y Microbiologia Clinica. 25-40. PMID 16373002 |
0.01 |
|
| 2010 |
Arribas JR, Pulido F. Response to: “Assessment of Baseline HIV Viral Load as a Risk Factor for Loss of Virologic Suppression in Protease Inhibitor-Based Monotherapy Trials” Jaids Journal of Acquired Immune Deficiency Syndromes. 53: 670. DOI: 10.1097/QAI.0B013E3181BEFC21 |
0.01 |
|
| 2009 |
Arribas JR. Drugs in traditional drug classes (nucleoside reverse transcriptase inhibitor/nonnucleoside reverse transcriptase inhibitor/protease inhibitors) with activity against drug-resistant virus (tipranavir, darunavir, etravirine). Current Opinion in Hiv and Aids. 4: 507-12. PMID 20048718 DOI: 10.1097/COH.0b013e328331b911 |
0.01 |
|
| 2009 |
Pozniak A, Gupta RK, Pillay D, Arribas J, Hill A. Causes and consequences of incomplete HIV RNA suppression in clinical trials. Hiv Clinical Trials. 10: 289-98. PMID 19906623 DOI: 10.1310/hct1005-289 |
0.01 |
|
| 2009 |
Sánchez-Conde M, Montes-Ramírez ML, Miralles P, Alvarez JM, Bellón JM, Ramírez M, Arribas JR, Gutiérrez I, López JC, Cosín J, Alvarez E, González J, Berenguer J. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers. Journal of Viral Hepatitis. 17: 280-6. PMID 19732322 DOI: 10.1111/j.1365-2893.2009.01180.x |
0.01 |
|
| 2009 |
Arribas JR, Mora M, Pascual-Pareja JF. Early versus deferred antiretroviral therapy for HIV. The New England Journal of Medicine. 361: 823; author reply 82. PMID 19701985 |
0.01 |
|
| 2009 |
Pulido F, Pérez-Valero I, Delgado R, Arranz A, Pasquau J, Portilla J, Rubio R, González-García J, Miralles P, Pérez-Elías MJ, Ocampo A, Hernando A, Estrada V, Clotet B, Podzamczer D, ... Arribas JR, et al. Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression. Antiviral Therapy. 14: 195-201. PMID 19430094 |
0.01 |
|
| 2009 |
Pascual-Pareja JF, Caminoa A, Larrauri C, González-GarcÃa J, Montes ML, DÃez J, Grande M, Arribas JR. HAART is associated with lower hepatic necroinflammatory activity in HIV-hepatitis C virus-coinfected patients with CD4 cell count of more than 350 cells/microl at the time of liver biopsy. Aids (London, England). 23: 971-5. PMID 19425223 |
0.01 |
|
| 2009 |
Martínez E, Arranz JA, Podzamczer D, Loncá M, Sanz J, Barragán P, Ribera E, Knobel H, Roca V, Gutiérrez F, Blanco JL, Mallolas J, Llibre JM, Clotet B, Dalmau D, ... ... Arribas JR, et al. A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression. Journal of Acquired Immune Deficiency Syndromes (1999). 51: 290-7. PMID 19398921 DOI: 10.1097/QAI.0b013e3181aa12d5 |
0.01 |
|
| 2009 |
Pascual Pareja JF, Montes ML, González-GarcÃa J, Arribas JR. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in European HIV-infected patients with anti-HCV antibodies. The Journal of Infectious Diseases. 199: 1556-7; author reply. PMID 19392631 DOI: 10.1086/598610 |
0.01 |
|
| 2009 |
Arribas JR, Delgado R, Arranz A, Muñoz R, Portilla J, Pasquau J, Pérez-Elias MJ, Iribarren JA, Rubio R, Ocampo A, Sánchez-Conde M, Knobel H, Arazo P, Sanz J, López-Aldeguer J, et al. Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and 2 nucleosides for maintenance therapy of HIV: 96-week analysis. Journal of Acquired Immune Deficiency Syndromes (1999). 51: 147-52. PMID 19349870 DOI: 10.1097/QAI.0b013e3181a56de5 |
0.01 |
|
| 2009 |
Pascual Pareja JF, Camino A, Larrauri J, López-Diéguez M, Montes ML, González-GarcÃa J, Peña JM, DÃez J, Arribas JR. [Factors associated with hepatic steatosis in human immunodeficiency virus and hepatits C virus coinfected patients]. Medicina ClãNica. 132: 208-13. PMID 19237003 DOI: 10.1016/j.medcli.2008.04.003 |
0.01 |
|
| 2009 |
Montes ML, Fraile JM, González JJ, Arribas JR. [Chorea during treatment with pegylated interferon and ribavirin in HIV-HCV coinfected patient]. Enfermedades Infecciosas Y Microbiología ClíNica. 27: 60-1. PMID 19218008 DOI: 10.1016/j.eimc.2008.02.001 |
0.01 |
|
| 2009 |
Montes ML, Castro JM, González J, San José Valdés B, Arribas JR. [Relationship between hepatic fibrosis measured by transient elastography and peripheral blood CD4+ lymphocyte values]. Enfermedades Infecciosas Y Microbiologia Clinica. 26: 561-3. PMID 19100176 DOI: 10.1157/13128273 |
0.01 |
|
| 2008 |
Arribas JR. [Role of the new molecules in antiretroviral therapy. Position of raltegravir]. Enfermedades Infecciosas Y Microbiología ClíNica. 26: 53-9. PMID 19572427 |
0.01 |
|
| 2008 |
Gallant JE, Arribas JR. Antiretroviral rounds. Is that "one pill" treatment enough? Aids Clinical Care. 20: 53-4. PMID 18724479 |
0.01 |
|
| 2008 |
Pulido F, Arribas JR. Noninferiority and lopinavir/ritonavir monotherapy trials. Aids (London, England). 22: 1696-7. PMID 18670240 DOI: 10.1097/QAD.0b013e32830a98ac |
0.01 |
|
| 2008 |
Seoane E, Resino S, Micheloud D, Moreno A, de Quiros JC, Lorente R, Rubio R, Gonzalez J, Pulido F, Arribas JR, Moreno S, Muñoz-Fernández M. Lipid and apoprotein profile in HIV-1-infected patients after CD4-guided treatment interruption. Journal of Acquired Immune Deficiency Syndromes (1999). 48: 455-9. PMID 18614926 DOI: 10.1097/QAI.0b013e31817bbc07 |
0.01 |
|
| 2008 |
Alvarez-Martínez MJ, Moreno A, Miró JM, Valls ME, Rivas PV, de Lazzari E, Sued O, Benito N, Domingo P, Ribera E, Santín M, Sirera G, Segura F, Vidal F, Rodríguez F, ... ... Arribas JR, et al. Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality. Diagnostic Microbiology and Infectious Disease. 62: 34-43. PMID 18554841 DOI: 10.1016/J.Diagmicrobio.2008.04.016 |
0.01 |
|
| 2008 |
Cameron DW, da Silva BA, Arribas JR, Myers RA, Bellos NC, Gilmore N, King MS, Bernstein BM, Brun SC, Hanna GJ. A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy. The Journal of Infectious Diseases. 198: 234-40. PMID 18540803 DOI: 10.1086/589622 |
0.01 |
|
| 2008 |
Asensio A, Cantón R, Vaqué J, Calbo-Torrecillas F, Herruzo R, Arribas JL, Sáenz MC. [Prevalence of infection by carbapenem-resistant Acinetobacter baumannii in Spain (1999-2005)]. Enfermedades Infecciosas Y Microbiologia Clinica. 26: 199-204. PMID 18381039 DOI: 10.1016/s0213-005x(08)72691-0 |
0.01 |
|
| 2008 |
Viciana P, Rubio R, Ribera E, Knobel H, Iribarren JA, Arribas JR, Pérez-Molina JA. [Longitudinal study on adherence, treatment satisfaction, and effectiveness of once-daily versus twice-daily antiretroviral therapy in a Spanish cohort of HIV-infected patients (CUVA study)]. Enfermedades Infecciosas Y Microbiología ClíNica. 26: 127-34. PMID 18358210 |
0.01 |
|
| 2008 |
Pulido F, Delgado R, Pérez-Valero I, González-García J, Miralles P, Arranz A, Hernando A, Arribas JR. Long-term (4 years) efficacy of lopinavir/ritonavir monotherapy for maintenance of HIV suppression. The Journal of Antimicrobial Chemotherapy. 61: 1359-61. PMID 18343802 DOI: 10.1093/jac/dkn103 |
0.01 |
|
| 2008 |
Seoane E, Resino S, Moreno S, de Quiros JC, Moreno A, Rubio R, Gonzalez-GarcÃa J, Arribas JR, Pulido F, Muñoz-Fernández MA. Immunological predictors of CD4+ T cell decline in antiretroviral treatment interruptions. Bmc Infectious Diseases. 8: 20. PMID 18302775 DOI: 10.1186/1471-2334-8-20 |
0.01 |
|
| 2008 |
Pulido F, Arribas JR, Delgado R, Cabrero E, González-García J, Pérez-Elias MJ, Arranz A, Portilla J, Pasquau J, Iribarren JA, Rubio R, Norton M. Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV. Aids (London, England). 22: F1-9. PMID 18097218 DOI: 10.1097/QAD.0b013e3282f4243b |
0.01 |
|
| 2008 |
Arribas JR, Pozniak AL, Gallant JE, Dejesus E, Gazzard B, Campo RE, Chen SS, McColl D, Holmes CB, Enejosa J, Toole JJ, Cheng AK. Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients: 144-week analysis. Journal of Acquired Immune Deficiency Syndromes (1999). 47: 74-8. PMID 17971715 DOI: 10.1097/QAI.0b013e31815acab8 |
0.01 |
|
| 2007 |
Bautista-Hernández V, Gutiérrez F, Pinar E, Gimeno JR, Arribas JM, García-Puente J, Ray VG, Arcas R, Valdés M. [Initial experience with the Impella left ventricular assist device for postcardiotomy cardiogenic shock and unprotected left coronary artery angioplasty in patients with a low left ventricular ejection fraction]. Revista Espanola De Cardiologia. 60: 984-7. PMID 17915156 DOI: 10.1157/13109653 |
0.01 |
|
| 2007 |
Arribas JR, Pulido F. Early virologic rebound in a pilot trial of ritonavir-boosted atanazavir as maintenance monotherapy. Journal of Acquired Immune Deficiency Syndromes (1999). 46: 118; author reply 11. PMID 17909317 DOI: 10.1097/qai.0b013e318061b780 |
0.01 |
|
| 2007 |
Saura D, Florenciano R, de la Morena G, Soria F, Espinosa MD, Arribas JM, Valdés-Chávarri M. Intraoperative myocardial rupture heralded by contrast echocardiography. Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography. 20: 906.e5-8. PMID 17617322 DOI: 10.1016/j.echo.2006.12.008 |
0.01 |
|
| 2007 |
Martà C, Peña JM, Bates I, Madero R, de José I, Pallardo LF, Arribas JR, Gonzalez-Garcia J, Gonzalez A, Vazquez JJ. Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003. Acta Obstetricia Et Gynecologica Scandinavica. 86: 409-15. PMID 17486461 DOI: 10.1080/00016340601148531 |
0.01 |
|
| 2007 |
GarcÃa-Bujalance S, Ladrón de Guevara C, González-GarcÃa J, Arribas JR, Zamora F, Gutiérrez A. Elevation of viral load by PCR and use of plasma preparation tubes for quantification of human immunodeficiency virus type 1. Journal of Microbiological Methods. 69: 384-6. PMID 17363096 DOI: 10.1016/j.mimet.2007.01.018 |
0.01 |
|
| 2007 |
Ribera E, Moreno S, Viciana P, Echevarría S, Flores J, Francés A, Gómez-Sirvent JL, González J, Hernández-Quero J, Lozano F, Mallolas J, Muñoz A, Ocampo A, Portilla J, Pulido F, ... ... Arribas JR, et al. [Spanish recommendations for proper use of enfuvirtide]. Enfermedades Infecciosas Y Microbiología ClíNica. 25: 131-42. PMID 17288910 |
0.01 |
|
| 2007 |
Quesada A, Campos L, Rubio C, Martín MA, Herranz P, Arribas JR, Pastor B, Zarallo J. [Three cases of early neurosyphilis in HIV patients]. Actas Dermo-Sifiliograficas. 97: 395-9. PMID 16956520 DOI: 10.1016/S0001-7310(06)73427-5 |
0.01 |
|
| 2007 |
Miro J, Pich J, Domingo P, Podzamczer D, Arribas J, Ribera E, Arrizabalaga J, Lonca M, De Lazzari E, Plana M. P1915 Immunological reconstitution in severely immunosuppressed antiretroviral-naïve patients (<100 CD4+T cells/mm 3) using a non–nucleoside reverse transcriptase inhibitor–based or boosted protease inhibitor–based ART regimen:3–year results International Journal of Antimicrobial Agents. 29: S549-S550. DOI: 10.1016/S0924-8579(07)71754-5 |
0.01 |
|
| 2006 |
McKinnon JE, Arribas JR, Pulido F, Delgado R, Mellors JW. The level of persistent HIV viremia does not increase after successful simplification of maintenance therapy to lopinavir/ritonavir alone. Aids (London, England). 20: 2331-5. PMID 17117019 DOI: 10.1097/Qad.0B013E32801189F6 |
0.01 |
|
| 2006 |
Pozniak AL, Gallant JE, DeJesus E, Arribas JR, Gazzard B, Campo RE, Chen SS, McColl D, Enejosa J, Toole JJ, Cheng AK. Tenofovir disoproxil fumarate, emtricitabine, and efavirenz versus fixed-dose zidovudine/lamivudine and efavirenz in antiretroviral-naive patients: virologic, immunologic, and morphologic changes--a 96-week analysis. Journal of Acquired Immune Deficiency Syndromes (1999). 43: 535-40. PMID 17057609 DOI: 10.1097/01.qai.0000245886.51262.67 |
0.01 |
|
| 2006 |
Escobar I, Pulido F, Pérez E, Arribas JR, García MP, Hernando A. [Pharmacoeconomic analysis of a maintenance strategy with lopinavir/ritonavir monotherapy in HIV-infected patients]. Enfermedades Infecciosas Y Microbiología ClíNica. 24: 490-4. PMID 16987465 |
0.01 |
|
| 2006 |
Youle M, Staszweski S, Clotet B, Arribas JR, Blaxhult A, Carosi G, De Jesus E, Di Perri G, Estrada V, Fisher M, Kovacs C, Kulasegaram R, Lazzarin A, Marriot D, Moñoz L, et al. Concomitant use of an active boosted protease inhibitor with enfuvirtide in treatment - Experienced, HIV-infected individuals: Recent data and consensus recommendations Hiv Clinical Trials. 7: 86-96. PMID 16798623 DOI: 10.1310/2XVK-PBGL-735N-WH72 |
0.01 |
|
| 2006 |
Miro JM, Lopez JC, Podzamczer D, Peña JM, Alberdi JC, Martínez E, Domingo P, Cosin J, Claramonte X, Arribas JR, Santín M, Ribera E. Discontinuation of primary and secondary Toxoplasma gondii prophylaxis is safe in HIV-infected patients after immunological restoration with highly active antiretroviral therapy: results of an open, randomized, multicenter clinical trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 43: 79-89. PMID 16758422 DOI: 10.1086/504872 |
0.01 |
|
| 2006 |
Peng JZ, Pulido F, Causemaker SJ, Li J, Lorenzo A, Cepeda C, GarcÃa Cabanillas JA, DaSilva B, Brun SC, Arribas J. Pharmacokinetics of lopinavir/ritonavir in HIV/hepatitis C virus-coinfected subjects with hepatic impairment. Journal of Clinical Pharmacology. 46: 265-74. PMID 16490802 DOI: 10.1177/0091270005284853 |
0.01 |
|
| 2006 |
Arribas JR, Pulido F, González-GarcÃa JJ, Miró JM. [Antiretroviral treatment in patient with advanced immunosuppression]. Medicina ClãNica. 126: 157-8; author reply . PMID 16472503 |
0.01 |
|
| 2006 |
Gallant JE, DeJesus E, Arribas JR, Pozniak AL, Gazzard B, Campo RE, Lu B, McColl D, Chuck S, Enejosa J, Toole JJ, Cheng AK. Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. The New England Journal of Medicine. 354: 251-60. PMID 16421366 DOI: 10.1056/NEJMoa051871 |
0.01 |
|
| 2006 |
MarÃn F, Pascual DA, Roldán V, Arribas JM, Ahumada M, Tornel PL, Oliver C, Gómez-Plana J, Lip GY, Valdés M. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. The American Journal of Cardiology. 97: 55-60. PMID 16377284 DOI: 10.1016/j.amjcard.2005.07.124 |
0.01 |
|
| 2006 |
Pascual DA, Arribas JM, Tornel PL, MarÃn F, Oliver C, Ahumada M, Gomez-Plana J, MartÃnez P, Arcas R, Valdes M. Preoperative statin therapy and troponin T predict early complications of coronary artery surgery. The Annals of Thoracic Surgery. 81: 78-83. PMID 16368340 DOI: 10.1016/j.athoracsur.2005.07.038 |
0.01 |
|
| 2006 |
Arribas JR. Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Triple Combination Tablet Drugs. 66: 1513-1514. DOI: 10.2165/00003495-200666110-00013 |
0.01 |
|
| 2005 |
Arribas J, Prieto A, DÃaz AC, Calleja M, Nava E. Calcifications of the breast in Onchocerca infection. The Breast Journal. 11: 507. PMID 16297118 DOI: 10.1111/j.1075-122X.2005.00165.x |
0.01 |
|
| 2005 |
Arribas JR, Pulido F, Delgado R, Lorenzo A, Miralles P, Arranz A, González-García JJ, Cepeda C, Hervás R, Paño JR, Gaya F, Carcas A, Montes ML, Costa JR, Peña JM. Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study). Journal of Acquired Immune Deficiency Syndromes (1999). 40: 280-7. PMID 16249701 DOI: 10.1097/01.qai.0000180077.59159.f4 |
0.01 |
|
| 2005 |
García Aparicio AM, Muñoz Fernández S, González J, Arribas JR, Peña JM, Vázquez JJ, Martínez ME, Coya J, Martín Mola E. Abnormalities in the bone mineral metabolism in HIV-infected patients. Clinical Rheumatology. 25: 537-9. PMID 16208429 DOI: 10.1007/s10067-005-0028-x |
0.01 |
|
| 2005 |
GarcÃa-Bujalance S, de Guevara CL, González-GarcÃa J, Arribas JR, Gutiérrez A. Comparison between sequence analysis and a line probe assay for testing genotypic resistance of human immunodeficiency virus type 1 to antiretroviral drugs. Journal of Clinical Microbiology. 43: 4186-8. PMID 16081972 DOI: 10.1128/JCM.43.8.4186-4188.2005 |
0.01 |
|
| 2005 |
González-GarcÃa JJ, Mahillo B, Hernández S, Pacheco R, Diz S, GarcÃa P, Esteban H, Arribas JR, Quereda C, Rubio R, DÃez J, Moreno S, Vázquez-RodrÃguez JJ. [Prevalences of hepatitis virus coinfection and indications for chronic hepatitis C virus treatment and liver transplantation in Spanish HIV-infected patients. The GESIDA 29/02 and FIPSE 12185/01 Multicenter Study]. Enfermedades Infecciosas Y Microbiologãa ClãNica. 23: 340-8. PMID 15970166 |
0.01 |
|
| 2005 |
Teira R, Suárez-Lozano I, Muñoz P, Viciana P, Lozano F, Galindo MJ, Terrón A, Vergara A, Geijo P, Arribas JR, Cosín J, Domingo P, Ribera E, Roca B, García-Alcalde ML, et al. [Changing trends in HIV epidemics: recent diagnoses in the Spanish VACH cohort (2000-2002)]. Enfermedades Infecciosas Y Microbiologia Clinica. 23: 213-7. PMID 15826546 DOI: 10.1157/13073147 |
0.01 |
|
| 2005 |
Montes ML, Pulido F, Barros C, Condes E, Rubio R, Cepeda C, Dronda F, Antela A, Sanz J, Navas E, Miralles P, Berenguer J, Pérez S, Zapata A, González-GarcÃa JJ, ... ... Arribas JR, et al. Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: frequency, characterization and risk factors. The Journal of Antimicrobial Chemotherapy. 55: 800-4. PMID 15761071 DOI: 10.1093/jac/dki063 |
0.01 |
|
| 2005 |
Solano VM, Hernández MJ, Montes FJ, Arribas JL. [Update of the cost of needlestick injuries in hospital healthcare personnel]. Gaceta Sanitaria. 19: 29-35. PMID 15745666 DOI: 10.1157/13071814 |
0.01 |
|
| 2005 |
Bautista-Hernández V, Gutierrez F, Ray VG, Arribas JM, García-Puente J, Casinello N, Arcas R. Constrictive pericarditis due to Coxiella burnetii. The Annals of Thoracic Surgery. 78: 326-8. PMID 15223458 DOI: 10.1016/S0003-4975(03)01361-4 |
0.01 |
|
| 2004 |
Asensi V, Martín-Roces E, Carton JA, Collazos J, Maradona JA, Alonso A, Medina M, Aburto JM, Martínez E, Rojo C, Bustillo E, Fernández C, Arribas JM. Perirenal fat diameter measured by echography could be an early predictor of lipodystrophy in HIV type 1-infected patients receiving highly active antiretroviral therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 39: 240-7. PMID 15307034 DOI: 10.1086/421774 |
0.01 |
|
| 2004 |
Arribas JR. The rise and fall of triple nucleoside reverse transcriptase inhibitor (NRTI) regimens. The Journal of Antimicrobial Chemotherapy. 54: 587-92. PMID 15282236 DOI: 10.1093/JAC/DKH384 |
0.01 |
|
| 2004 |
Arribas JL, Hernández-Navarrete MJ, Solano VM. [Adult vaccination update]. Enfermedades Infecciosas Y Microbiologia Clinica. 22: 342-54. PMID 15228902 DOI: 10.1157/13063047 |
0.01 |
|
| 2004 |
Asensi V, Valle E, Meana A, Fierer J, Celada A, Alvarez V, Paz J, Coto E, Carton JA, Maradona JA, Dieguez A, Sarasúa J, Ocaña MG, Arribas JM. In vivo interleukin-6 protects neutrophils from apoptosis in osteomyelitis. Infection and Immunity. 72: 3823-8. PMID 15213123 DOI: 10.1128/IAI.72.7.3823-3828.2004 |
0.01 |
|
| 2004 |
Pulido F, Arribas JR, Miró JM, Costa MA, González J, Rubio R, Peña JM, Torralba M, Lonca M, Lorenzo A, Cepeda C, Vázquez JJ, Gatell JM. Clinical, virologic, and immunologic response to efavirenz-or protease inhibitor-based highly active antiretroviral therapy in a cohort of antiretroviral-naive patients with advanced HIV infection (EfaVIP 2 study). Journal of Acquired Immune Deficiency Syndromes (1999). 35: 343-50. PMID 15097150 DOI: 10.1097/00126334-200404010-00003 |
0.01 |
|
| 2004 |
Bautista-Hernández V, Gutierrez F, Capel A, García-Puente J, Arribas JM, Ray VG, Robles D, Arcas R. Endovascular repair of concomitant celiac trunk and abdominal aortic aneurysms in a patient with Behçet's disease. Journal of Endovascular Therapy : An Official Journal of the International Society of Endovascular Specialists. 11: 222-5. PMID 15056032 DOI: 10.1583/03-1037.1 |
0.01 |
|
| 2004 |
Berenguer J, Laguna F, López-Aldeguer J, Moreno S, Arribas JR, Arrizabalaga J, Baraia J, Casado JL, CosÃn J, Polo R, González-GarcÃa J, Iribarren JA, Kindelán JM, López-Bernaldo de Quirós JC, López-Vélez R, et al. Prevention of opportunistic infections in adult and adolescent patients with HIV infection. GESIDA/National AIDS Plan guidelines, 2004 [correction]. Enfermedades Infecciosas Y Microbiologãa ClãNica. 22: 160-76. PMID 14987537 |
0.01 |
|
| 2004 |
Perez-Elias MJ, Garcia-Arota I, Muñoz V, Santos I, Sanz J, Abraira V, Arribas JR, González J, Moreno A, Dronda F, Antela A, Pumares M, Martí-Belda P, Casado JL, Geijos P, et al. Phenotype or virtual phenotype for choosing antiretroviral therapy after failure: a prospective, randomized study. Antiviral Therapy. 8: 577-84. PMID 14760891 |
0.01 |
|
| 2004 |
Arribas JM, Pascual DA, Gutiérrez F, Ray V, García-Puente J, Valdés M, Arcas R. Successful biventricular assistance after heart transplantation. The Annals of Thoracic Surgery. 77: 720-1. PMID 14759475 DOI: 10.1016/j.athoracsur.2003.05.002 |
0.01 |
|
| 2004 |
López-Vélez R, Videla S, Márquez M, Boix V, Jiménez-Mejías ME, Górgolas M, Arribas JR, Salas A, Laguna F, Sust M, Cañavate C, Alvar J. Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients. The Journal of Antimicrobial Chemotherapy. 53: 540-3. PMID 14739148 DOI: 10.1093/jac/dkh084 |
0.01 |
|
| 2004 |
Soriano V, Miró JM, García-Samaniego J, Torre-Cisneros J, Núñez M, del Romero J, Martín-Carbonero L, Castilla J, Iribarren JA, Quereda C, Santín M, González J, Arribas JR, Santos I, Hernández-Quero J, et al. Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations. Journal of Viral Hepatitis. 11: 2-17. PMID 14738553 DOI: 10.1046/j.1365-2893.2003.00491.x |
0.01 |
|
| 2004 |
Arribas JR. Efavirenz: enhancing the gold standard. International Journal of Std & Aids. 6-14. PMID 14617398 DOI: 10.1258/095646203322491824 |
0.01 |
|
| 2003 |
Asensi V, Alvarez V, Valle E, Meana A, Fierer J, Coto E, Carton JA, Maradona JA, Paz J, Dieguez MA, de la Fuente B, Moreno A, Rubio S, Tuya MJ, Sarasúa J, ... ... Arribas JM, et al. IL-1 alpha (-889) promoter polymorphism is a risk factor for osteomyelitis. American Journal of Medical Genetics. Part A. 119: 132-6. PMID 12749050 DOI: 10.1002/ajmg.a.20137 |
0.01 |
|
| 2003 |
Pérez-Olmeda M, Núñez M, Romero M, González J, Castro A, Arribas JR, Pedreira J, Barreiro P, García-Samaniego J, Martín-Carbonero L, Jiménez-Nácher I, Soriano V. Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients. Aids (London, England). 17: 1023-8. PMID 12700452 DOI: 10.1097/00002030-200305020-00011 |
0.01 |
|
| 2003 |
Pulido F, Arribas JR. Treatment of advanced HIV infection. The Journal of Antimicrobial Chemotherapy. 51: 225-7. PMID 12562685 DOI: 10.1093/JAC/DKG065 |
0.01 |
|
| 2003 |
Suárez-Lozano I, Fajardo JM, Garrido M, Roca B, García-Alcalde ML, Geijo P, Selma D, Lozano F, Teira R, Viciana P, Pérez-Cortés S, Domingo P, Menchero A, Galindo MJ, Cosín J, ... ... Arribas JR, et al. Epidemiological trends of HIV infection in Spain: preventative plans have to be oriented to new target populations (Spanish VACH Cohort). Aids (London, England). 16: 2496-9. PMID 12461432 DOI: 10.1097/01.AIDS.0000042931.55529.82 |
0.01 |
|
| 2003 |
García-Bujalance S, Arribas JR, Vázquez JJ, Ladrón de Guevara C. [Diarrhea and weight loss in a male after a recent trip to Guatemala]. Enfermedades Infecciosas Y Microbiologia Clinica. 20: 473-4. PMID 12425882 DOI: 10.1016/s0213-005x(02)72844-9 |
0.01 |
|
| 2002 |
Arribas JR, Pulido F. Underpowered clinical trials of antiretroviral treatment. Jama. 288: 2120; author reply 2. PMID 12413367 DOI: 10.1001/jama.288.17.2120 |
0.01 |
|
| 2002 |
Reche M, Caballero T, López-Trascasa M, Arribas JR, López Serrano MC. Angioedema and transient acquired C1 inhibitor functional deficiency in HIV infection: case report. Aids (London, England). 16: 1561. PMID 12131197 DOI: 10.1097/00002030-200207260-00016 |
0.01 |
|
| 2002 |
Arribas JR, Pulido F, Miró JM, Costa MA, González J, Rubio R, Peña JM, Torralba M, Lonca M, Lorenzo A, Del Palacio A, Vázquez JJ, Gatell JM. High effectiveness of efavirenz-based highly active antiretroviral therapy in HIV-1-infected patients with fewer than 100 CD4 cells/microl and opportunistic diseases: the EfaVIP Study (Efavirenz in Very Immunosuppressed Patients). Aids (London, England). 16: 1554-6. PMID 12131195 DOI: 10.1097/00002030-200207260-00014 |
0.01 |
|
| 2002 |
Walmsley S, Bernstein B, King M, Arribas J, Beall G, Ruane P, Johnson M, Johnson D, Lalonde R, Japour A, Brun S, Sun E. Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection. The New England Journal of Medicine. 346: 2039-46. PMID 12087139 DOI: 10.1056/Nejmoa012354 |
0.01 |
|
| 2002 |
Asensio A, Cantón R, Vaqué J, Rosselló J, Arribas JL. [Antimicrobial use in Spanish hospitals (EPINE, 1990-1999)]. Medicina Clinica. 118: 731-6. PMID 12049705 |
0.01 |
|
| 2002 |
Asensio A, Cantón R, Vaqué J, Rosselló J, Arribas JL. [Etiology of hospital-acquired infections in Spanish hospitals (EPINE, 1990-1999)]. Medicina Clinica. 118: 725-30. PMID 12049704 |
0.01 |
|
| 2002 |
Falcó V, RodrÃguez D, Ribera E, MartÃnez E, Miró JM, Domingo P, Diazaraque R, Arribas JR, González-GarcÃa JJ, Montero F, Sánchez L, Pahissa A. Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 34: 838-46. PMID 11850865 DOI: 10.1086/339041 |
0.01 |
|
| 2002 |
Romero M, Perez-Olmeda M, Garcia-Samaniego J, Gonzalez J, Castro A, Arribas JR, Pedreira J, Soriano V. Treatment of chronic hepatitis C with pegylated interferon plus ribavirin in HIV-infected patients Journal of Hepatology. 36: 107. DOI: 10.1016/S0168-8278(02)80380-4 |
0.01 |
|
| 2001 |
Berenguer J, González J, Pulido F, Padilla B, Casado JL, Rubio R, Arribas JR. Discontinuation of secondary prophylaxis in patients with cytomegalovirus retinitis who have responded to highly active antiretroviral therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 34: 394-7. PMID 11753827 DOI: 10.1086/338401 |
0.01 |
|
| 2001 |
Gallego O, de Mendoza C, Pérez-Elías MJ, Guardiola JM, Pedreira J, Dalmau D, Gónzalez J, Moreno A, Arribas JR, Rubio A, García-Arata I, Leal M, Domingo P, Soriano V. Drug resistance in patients experiencing early virological failure under a triple combination including indinavir. Aids (London, England). 15: 1701-6. PMID 11546946 DOI: 10.1097/00002030-200109070-00014 |
0.01 |
|
| 2000 |
Quereda C, Corral I, Laguna F, Valencia ME, Tenorio A, Echeverria JE, Navas E, Martín-Dávila P, Moreno A, Moreno V, Gonzalez-Lahoz JM, Arribas JR, Guerrero A. Diagnostic utility of a multiplex herpesvirus PCR assay performed with cerebrospinal fluid from human immunodeficiency virus-infected patients with neurological disorders. Journal of Clinical Microbiology. 38: 3061-7. PMID 10921978 DOI: 10.1128/JCM.38.8.3061-3067.2000 |
0.01 |
|
| 2000 |
Arribas JR, Hernández-Albujar S, González-GarcÃa JJ, Peña JM, Gonzalez A, Cañedo T, Madero R, Vazquez JJ, Powderly WG. Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis. Aids (London, England). 14: 979-85. PMID 10853979 DOI: 10.1097/00002030-200005260-00009 |
0.01 |
|
| 2000 |
Pérez-Olmeda M, González J, García-Samaniego J, Arribas JR, Peña JM, Soriano V. Interferon plus ribavirin in HIV-infected patients with chronic hepatitis C. Journal of Acquired Immune Deficiency Syndromes (1999). 22: 308-9. PMID 10770353 DOI: 10.1097/00126334-199911010-00014 |
0.01 |
|
| 2000 |
Pérez-Olmeda M, Gónzalez J, Garcia-Samaniego J, Arribas J, Peña J, Soriano V. IFN plus ribavirin in HIV+ patients with chronic hepatitis C Journal of Hepatology. 32: 114. DOI: 10.1016/S0168-8278(00)80773-4 |
0.01 |
|
| 1999 |
Pérez-Olmeda M, González J, García-Samaniego J, Arribas JR, Peña JM, Soriano V. Interferon Plus Ribavirin in HIV-Infected Patients With Chronic Hepatitis C Journal of Acquired Immune Deficiency Syndromes. 22: 308. DOI: 10.1097/00042560-199911010-00014 |
0.01 |
|
| 1996 |
De Diego JA, Penin P, Arribas JR, Vázquez E, Vázquez JJ. A Clinical-Parasitological Monotherapy Cure in the Treatment of Experimental Infection by a Highly Virulent Strain of Toxoplasma gondii Folia Microbiologica. 41: 513-516. PMID 9131805 DOI: 10.1007/BF02814670 |
0.01 |
|
| Hide low-probability matches. |